<SEC-DOCUMENT>0001214659-21-008684.txt : 20210816
<SEC-HEADER>0001214659-21-008684.hdr.sgml : 20210816
<ACCEPTANCE-DATETIME>20210816162237
ACCESSION NUMBER:		0001214659-21-008684
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		20
CONFORMED PERIOD OF REPORT:	20210811
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210816
DATE AS OF CHANGE:		20210816

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TRANSACT TECHNOLOGIES INC
		CENTRAL INDEX KEY:			0001017303
		STANDARD INDUSTRIAL CLASSIFICATION:	COMPUTER PERIPHERAL EQUIPMENT, NEC [3577]
		IRS NUMBER:				061456680
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-21121
		FILM NUMBER:		211178608

	BUSINESS ADDRESS:	
		STREET 1:		ONE HAMDEN CENTER
		STREET 2:		2319 WHITNEY AVENUE, SUITE 3B
		CITY:			HAMDEN
		STATE:			CT
		ZIP:			06518
		BUSINESS PHONE:		203-859-6800

	MAIL ADDRESS:	
		STREET 1:		ONE HAMDEN CENTER
		STREET 2:		2319 WHITNEY AVENUE, SUITE 3B
		CITY:			HAMDEN
		STATE:			CT
		ZIP:			06518
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>r8122108k.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:TACT="http://transact-tech.com/20210811">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_037_TACT_transact%2Dtech.com_20210811 -->
<!-- Field: Set; Name: xdx; ID: xdx_040_20210811_20210811 -->
<!-- Field: Set; Name: xdx; ID: xdx_05D_edei%2D%2DEntityCentralIndexKey_0001017303 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
  <ix:hidden>
    <ix:nonNumeric contextRef="From2021-08-11to2021-08-11" name="dei:EntityCentralIndexKey">0001017303</ix:nonNumeric>
    <ix:nonNumeric contextRef="From2021-08-11to2021-08-11" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
    </ix:hidden>
  <ix:references>
    <link:schemaRef xlink:href="tact-20210811.xsd" xlink:type="simple" />
    </ix:references>
  <ix:resources>
    <xbrli:context id="From2021-08-11to2021-08-11">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001017303</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-11</xbrli:startDate>
        <xbrli:endDate>2021-08-11</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    </ix:resources>
  </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 14pt"><b>UNITED STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 14pt"><b>SECURITIES AND
EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 12pt"><b>Washington, D.C.
20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 18pt"><b>FORM <span id="xdx_902_edei--DocumentType_c20210811__20210811_zp59bAFxV7Bj"><ix:nonNumeric contextRef="From2021-08-11to2021-08-11" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of Report (Date of earliest event reported):
<span id="xdx_904_edei--DocumentPeriodEndDate_c20210811__20210811_zmygxBGRlMt"><ix:nonNumeric contextRef="From2021-08-11to2021-08-11" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">August 11, 2021</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b>&#160;<img src="transactlogo_small.jpg" alt="" /></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_906_edei--EntityRegistrantName_c20210811__20210811_zPZEsTa6aaLh"><ix:nonNumeric contextRef="From2021-08-11to2021-08-11" name="dei:EntityRegistrantName">TransAct Technologies Incorporated</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Exact name of registrant as specified in its
charter)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 34%; layout-grid-mode: line; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_905_edei--EntityIncorporationStateCountryCode_c20210811__20210811_zNOGSrtfZStk"><ix:nonNumeric contextRef="From2021-08-11to2021-08-11" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="width: 33%; layout-grid-mode: line; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90C_edei--EntityFileNumber_c20210811__20210811_zxv4kODX8Wil"><ix:nonNumeric contextRef="From2021-08-11to2021-08-11" name="dei:EntityFileNumber">0-21121</ix:nonNumeric></span></b></span></td>
    <td style="width: 33%; layout-grid-mode: line; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_908_edei--EntityTaxIdentificationNumber_c20210811__20210811_znqzse9bWGR8"><ix:nonNumeric contextRef="From2021-08-11to2021-08-11" name="dei:EntityTaxIdentificationNumber">06-1456680</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="layout-grid-mode: line; text-align: center"><span style="font-size: 10pt"><b>(State or other jurisdiction of <br />
incorporation)</b></span></td>
    <td style="layout-grid-mode: line; text-align: center"><span style="font-size: 10pt"><b>(Commission file number)</b></span></td>
    <td style="layout-grid-mode: line; text-align: center"><span style="font-size: 10pt"><b>(I.R.S. employer identification no.)</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 50%; layout-grid-mode: line; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90C_edei--EntityAddressAddressLine1_c20210811__20210811_zFGL3jq39eo3"><ix:nonNumeric contextRef="From2021-08-11to2021-08-11" name="dei:EntityAddressAddressLine1">One Hamden Center</ix:nonNumeric></span></b></span></td>
    <td style="width: 50%; layout-grid-mode: line; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="layout-grid-mode: line; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_905_edei--EntityAddressAddressLine2_c20210811__20210811_zhMO5z1Zi7q6"><ix:nonNumeric contextRef="From2021-08-11to2021-08-11" name="dei:EntityAddressAddressLine2">2319 Whitney Ave</ix:nonNumeric></span>, <span id="xdx_908_edei--EntityAddressAddressLine3_c20210811__20210811_zWj17H6N2eQf"><ix:nonNumeric contextRef="From2021-08-11to2021-08-11" name="dei:EntityAddressAddressLine3">Suite 3B</ix:nonNumeric></span>, <span id="xdx_90A_edei--EntityAddressCityOrTown_c20210811__20210811_ziM4No1rs6q5"><ix:nonNumeric contextRef="From2021-08-11to2021-08-11" name="dei:EntityAddressCityOrTown">Hamden</ix:nonNumeric></span>, <span id="xdx_905_edei--EntityAddressStateOrProvince_c20210811__20210811_zw3gPM7CFtzc"><ix:nonNumeric contextRef="From2021-08-11to2021-08-11" name="dei:EntityAddressStateOrProvince">CT</ix:nonNumeric></span></b></span></td>
    <td style="layout-grid-mode: line; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90F_edei--EntityAddressPostalZipCode_c20210811__20210811_zLvF7grx0iMd"><ix:nonNumeric contextRef="From2021-08-11to2021-08-11" name="dei:EntityAddressPostalZipCode">06518</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="layout-grid-mode: line; text-align: center"><span style="font-size: 10pt"><b>(Address of principal executive offices)</b></span></td>
    <td style="layout-grid-mode: line; text-align: center"><span style="font-size: 10pt"><b>(Zip Code)</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Registrant&#8217;s telephone number, including
area code: <span id="xdx_90A_edei--CityAreaCode_c20210811__20210811_z6AjiTETBj6h"><ix:nonNumeric contextRef="From2021-08-11to2021-08-11" name="dei:CityAreaCode">(203)</ix:nonNumeric></span> <span id="xdx_905_edei--LocalPhoneNumber_c20210811__20210811_zhASGzU8DJei"><ix:nonNumeric contextRef="From2021-08-11to2021-08-11" name="dei:LocalPhoneNumber">859-6800</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Former Name or Former Address, if Changed Since
Last Report): Not applicable.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Wingdings"><span id="xdx_900_edei--WrittenCommunications_c20210811__20210811_zlqW0uYlP4id"><ix:nonNumeric contextRef="From2021-08-11to2021-08-11" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span>
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Wingdings"><span id="xdx_904_edei--SolicitingMaterial_c20210811__20210811_zdppis9CNYqb"><ix:nonNumeric contextRef="From2021-08-11to2021-08-11" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span>
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240-14a-12)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Wingdings"><span id="xdx_90F_edei--PreCommencementTenderOffer_c20210811__20210811_z23WeKcHsZP9"><ix:nonNumeric contextRef="From2021-08-11to2021-08-11" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span>
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Wingdings"><span id="xdx_901_edei--PreCommencementIssuerTenderOffer_c20210811__20210811_z1tswtq4s3V5"><ix:nonNumeric contextRef="From2021-08-11to2021-08-11" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span>
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Securities registered pursuant to Section 12(b)
of the Act:</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border: black 1pt solid; width: 34%; layout-grid-mode: line; text-align: center">Title of each class</td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 23%; layout-grid-mode: line; text-align: center">Trading Symbol(s)</td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 43%; layout-grid-mode: line; text-align: center">Name of each exchange on which registered</td></tr>
  <tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; layout-grid-mode: line; text-align: center"><span id="xdx_900_edei--Security12bTitle_c20210811__20210811_zy13DErMUcO3"><ix:nonNumeric contextRef="From2021-08-11to2021-08-11" name="dei:Security12bTitle">Common stock, par value $.01 per share</ix:nonNumeric></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; layout-grid-mode: line; text-align: center"><span id="xdx_909_edei--TradingSymbol_c20210811__20210811_zZzb9uQiqkDi"><ix:nonNumeric contextRef="From2021-08-11to2021-08-11" name="dei:TradingSymbol">TACT</ix:nonNumeric></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; layout-grid-mode: line; text-align: center"><span id="xdx_905_edei--SecurityExchangeName_c20210811__20210811_zmZI5QBtVx2j"><ix:nonNumeric contextRef="From2021-08-11to2021-08-11" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NASDAQ Global Market</ix:nonNumeric></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1pt">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (17 CFR &#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1pt; text-align: right">Emerging Growth Company <span style="font: 10pt Wingdings"><span id="xdx_902_edei--EntityEmergingGrowthCompany_c20210811__20210811_zC0J1amUJgn9"><ix:nonNumeric contextRef="From2021-08-11to2021-08-11" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1pt; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font: 10pt Wingdings">&#168;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 2px solid; margin-top: 8pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">&#160;</td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: left; width: 100%"><span style="font-size: 10pt">&#160;</span></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 71.1pt"><b>Item 1.01</b></td><td style="text-align: justify"><b>Entry into a Material Definitive Agreement</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 16, 2021, TransAct Technologies Incorporated
(&#8220;TransAct&#8221;) closed its previously announced underwritten public offering (the &#8220;Offering&#8221;). TransAct sold an aggregate
of 732,500 shares of common stock, $.01 par value per share (the &#8220;Shares&#8221;), at a public offering price of $14.50 per Share.
The Shares were issued and sold pursuant to an underwriting agreement, dated August 12, 2021 (the &#8220;Underwriting Agreement&#8221;)
between TransAct and Roth Capital Partners, LLC, as representative of the several underwriters named therein (the &#8220;Underwriters&#8221;).
Pursuant to the Underwriting Agreement, the Shares are being sold to the Underwriters at a discount of 6% to the public offering price,
and TransAct has agreed to reimburse the Underwriters for certain fees and expenses. The anticipated net proceeds of approximately $9.8
million from the Offering, after deducting underwriting discounts and commissions and estimated offering expenses payable by TransAct,
are expected to be used for working capital and other general corporate purposes, which may include funding the further development of
TransAct&#8217;s food service technology business and related sales, marketing and product development efforts, technology improvements
and personnel costs in support of TransAct&#8217;s growth strategy. Under the terms of the Underwriting Agreement, TransAct granted the
Underwriters a 30-day over-allotment option to purchase up to an additional 109,875 shares of its common stock at the public offering
price, less the underwriting discounts and commissions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Underwriting Agreement included customary
representations, warranties and covenants of the parties, and customary conditions to closing, obligations of the parties and termination
provisions. Additionally, under the terms of the Underwriting Agreement, TransAct has agreed to indemnify the Underwriters against certain
liabilities, including liabilities under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), or to contribute to
payments the Underwriter may be required to make in respect of these liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Offering was made pursuant to an effective
shelf registration statement on Form S-3 (File No. 333-248055) filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;)
on August 17, 2020 and declared effective on August 21, 2020 and an additional registration statement on Form S-3 (File No. 333-258738)
filed with the SEC on August 11, 2021 pursuant to Rule 462(b) promulgated under the Securities Act , which became immediately effective
upon filing. A final prospectus supplement and accompanying base prospectus relating to the Offering were filed with the SEC on August
13, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A copy of the Underwriting Agreement is filed
herewith as Exhibit 1.1 and is incorporated herein by reference. The foregoing description of the material terms of the Underwriting Agreement
does not purport to be complete and is qualified in its entirety by reference to such exhibit. A copy of the legal opinion of Day Pitney
LLP relating to the legality of the Shares is filed herewith as Exhibit 5.1.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 2px solid; margin-top: 8pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">&#160;</td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: left; width: 100%"><span style="font-size: 10pt">&#160;</span></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Forward-Looking Statements </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain statements in this report include forward-looking
statements. Forward-looking statements generally can be identified by the use of forward-looking terminology, such as &#8220;may,&#8221;
&#8220;will,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;estimate,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221;
&#8220;project,&#8221; &#8220;plan&#8221; or &#8220;continue,&#8221; or the negative thereof, or other similar words. All forward-looking
statements involve risks and uncertainties, including, but not limited to, the adverse effects of the COVID-19 pandemic, related vaccination
rates and the emergence of virus variants on TransAct&#8217;s business, operations, financial condition, results of operations and capital
resources, including as a result of supply chain disruptions, shutdowns and/or operational restrictions imposed on TransAct&#8217;s customers,
an inability of customers to make payments on time or at all, diversion of management attention, necessary modifications to business practices
and operations, cost cutting measures that TransAct has made and may continue to make, a possible future reduction in the value of goodwill
or other intangible assets, inadequate manufacturing capacity or a shortfall or excess of inventory as a result of difficulty in predicting
manufacturing requirements due to volatile economic conditions, price increases or decreased availability of component parts or raw materials,
exchange rate fluctuations, volatility of and decreases in trading prices of the TransAct common stock and the availability of needed
financing on acceptable terms or at all; the ability to successfully develop new products that garner customer acceptance and generate
sales, both domestically and internationally, in the face of substantial competition; reliance on an unrelated third party to develop,
maintain and host certain web-based food service application software and develop and maintain selected components of TransAct&#8217;s
downloadable software applications pursuant to a non-exclusive license agreement, and the risk that interruptions in TransAct&#8217;s
relationship with that third party could materially impair TransAct&#8217;s ability to provide services to food service technology customers
on a timely basis or at all and could require substantial expenditures to find or develop alternative software products; the ability to
successfully transition the business into the food service technology market; the ability to fully remediate a previously disclosed material
weakness in internal control over financial reporting; risks associated with potential future acquisitions; general economic conditions;
dependence on contract manufacturers for the assembly of a large portion of TransAct&#8217;s products in Asia; dependence on significant
suppliers; TransAct&#8217;s ability to recruit and retain quality employees as it grows; dependence on third parties for sales outside
the United States; dependence on technology licenses from third parties; marketplace acceptance of new products; risks associated with
foreign operations; the availability of third-party components at reasonable prices; price wars or other significant pricing pressures
affecting TransAct&#8217;s products in the United States or abroad; increased product costs or reduced customer demand for TransAct&#8217;s
products due to changes in U.S. policy that may result in trade wars or tariffs; TransAct&#8217;s ability to protect intellectual property;
the effect of the United Kingdom&#8217;s withdrawal from the European Union; and other risk factors detailed in TransAct&#8217;s Annual
Report on Form 10-K for the year ended December 31, 2020, and other reports filed with the SEC. Actual results may differ materially from
those discussed in, or implied by, the forward-looking statements. The forward-looking statements speak only as of the date of this report,
and TransAct assumes no duty to update them to reflect new, changing or unanticipated events or circumstances, except as required by applicable
law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 71.1pt"><b>Item 8.01</b></td><td style="text-align: justify"><b>Other Events.</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 11, 2021, TransAct issued a press release
announcing the commencement of the Offering. The press release is filed herewith as Exhibit 99.1 and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 12, 2021, TransAct issued a press release
announcing the pricing of the Offering. The press release is filed herewith as Exhibit 99.2 and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 16, 2021, TransAct issued a press release
announcing the completion of the Offering. The press release is filed herewith as Exhibit 99.3 and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 71.1pt"><b>Item 9.01</b></td><td style="text-align: justify"><b>Financial Statements and Exhibits.</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 35.1pt">(d)</td><td>Exhibits</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="width: 13%; layout-grid-mode: line; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">1.1</span></td>
    <td style="width: 87%; layout-grid-mode: line; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="ex1_1.htm">Underwriting Agreement between TransAct Technologies Incorporated and Roth Capital Partners, LLC, as representative, dated August 12, 2021</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="layout-grid-mode: line; text-align: justify">&#160;</td>
    <td style="layout-grid-mode: line; text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="layout-grid-mode: line; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">5.1</span></td>
    <td style="layout-grid-mode: line; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="ex5_1.htm">Opinion of Day Pitney LLP</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="layout-grid-mode: line; text-align: justify">&#160;</td>
    <td style="layout-grid-mode: line; text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="layout-grid-mode: line; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">23.1</span></td>
    <td style="layout-grid-mode: line; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="ex5_1.htm">Consent of Day Pitney LLP (included in Exhibit 5.1)</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="layout-grid-mode: line; text-align: justify">&#160;</td>
    <td style="layout-grid-mode: line; text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="layout-grid-mode: line; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">99.1</span></td>
    <td style="layout-grid-mode: line; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="ex99_2.htm">Press Release dated August 11, 2021 regarding commencement of public offering</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="layout-grid-mode: line; text-align: justify">&#160;</td>
    <td style="layout-grid-mode: line; text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="layout-grid-mode: line; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">99.2</span></td>
    <td style="layout-grid-mode: line; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="ex99_2.htm">Press Release dated August 12, 2021 regarding pricing of public offering</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="layout-grid-mode: line; text-align: justify">&#160;</td>
    <td style="layout-grid-mode: line; text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="layout-grid-mode: line; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">99.3</span></td>
    <td style="layout-grid-mode: line; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="ex99_3.htm">Press Release dated August 16, 2021 regarding completion of public offering</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="layout-grid-mode: line; text-align: justify">&#160;</td>
    <td style="layout-grid-mode: line; text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="layout-grid-mode: line; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">104</span></td>
    <td style="layout-grid-mode: line; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 2px solid; margin-top: 8pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">&#160;</td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: left; width: 100%"><span style="font-size: 10pt">&#160;</span></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td>&#160;</td>
    <td colspan="3" style="layout-grid-mode: line">&#160;</td>
    </tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="3" style="layout-grid-mode: line"><span style="font-size: 10pt"><b>TRANSACT TECHNOLOGIES INCORPORATED</b></span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="layout-grid-mode: line">&#160;</td>
    <td colspan="2" style="layout-grid-mode: line">&#160;</td></tr>
  <tr>
    <td style="width: 50%">&#160;</td>
    <td style="vertical-align: top; layout-grid-mode: line; width: 5%"><span style="font-size: 10pt">By:</span></td>
    <td style="vertical-align: bottom; layout-grid-mode: line; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; layout-grid-mode: line; width: 44%"><span style="font-size: 10pt">/s/ Steven A. DeMartino</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top; layout-grid-mode: line">&#160;</td>
    <td style="vertical-align: bottom; layout-grid-mode: line">&#160;</td>
    <td style="vertical-align: bottom; layout-grid-mode: line"><span style="font-size: 10pt">Steven A. DeMartino</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top; layout-grid-mode: line">&#160;</td>
    <td style="vertical-align: bottom; layout-grid-mode: line">&#160;</td>
    <td style="vertical-align: bottom; layout-grid-mode: line"><span style="font-size: 10pt">President, Chief Financial Officer, Treasurer and Secretary</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date: August 16, 2021</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2px solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdsKwjAMhp+g7xB6PeY2GOguLSriFBki3hYXpbg1I62HPZJvad0QQyCn/8svZSRXtDQNMpzmVQkHbLtGe4QKL8hozxgUar0pINQKr8Z51tYP4w9UFBgMTB7PdNgPyodxWBeQTCdpNsnS0BT5DPZbKb53RfZiarTe6Aa0rWHP1LFBr7kfPxz0iyy1/eB0RHaGbAFpnIznN2RJmsGOHvpJfHNQlkqKaAghV0z37mtzd55aWDTYBi83ov8UH+dPSSk= -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ex1_1.htm
<DESCRIPTION>EXHIBIT 1.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 1.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>732,500 Shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TRANSACT TECHNOLOGIES INCORPORATED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>UNDERWRITING AGREEMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">August 12, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Roth Capital Partners, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">888 San Clemente Drive</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Newport Beach, California 92660</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">as Representative of the several</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Underwriters named in Schedule I hereto</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">TransAct Technologies Incorporated,
a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), proposes, subject to the terms and conditions contained herein, to sell to
Roth Capital Partners, LLC (&ldquo;<U>Roth</U>&rdquo;) and the other underwriters named on Schedule I hereto (the &ldquo;<U>Underwriters</U>&rdquo;),
for whom Roth is acting as representative (the &ldquo;<U>Representative</U>&rdquo;), an aggregate of 732,500 shares (the &ldquo;<U>Firm
Shares</U>&rdquo;) of the Company&rsquo;s common stock, $.01 par value per share (the &ldquo;<U>Common Stock</U>&rdquo;). The respective
amounts of the Firm Shares to be purchased by each of the several Underwriters are set forth opposite their names on Schedule I hereto.
In addition, the Company proposes to grant to the Underwriters an option to purchase up to an additional 109,875 shares (the &ldquo;<U>Option
Shares</U>&rdquo;) of Common Stock for the purpose of covering over-allotments in connection with the sale of the Firm Shares. The Firm
Shares and the Option Shares are collectively called the &ldquo;<U>Shares</U>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The Company has prepared and
filed in conformity with the requirements of the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), and the
published rules and regulations thereunder (the &ldquo;<U>Rules</U>&rdquo;) adopted by the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;)
a &ldquo;shelf&rdquo; registration statement on Form&nbsp;S-3 (No. 333-248055), which became effective as of August 21, 2020, including
a base prospectus (the &ldquo;<U>Base Prospectus</U>&rdquo;) relating to common stock, preferred stock, debt securities and warrants or
other rights of the Company that may be sold from time to time by the Company in accordance with Rule 415 of the Securities Act, and such
amendments thereof as may have been required to the date of this Agreement (such registration statement, including all exhibits and all
documents and information deemed to be part of the registration statement by incorporation by reference or otherwise, as amended from
time to time, including the information (if any) contained in the form of final prospectus filed with the Commission pursuant to Rule
424(b) of the Rules and deemed to be part thereof at the time of effectiveness pursuant to Rule 430A of the Rules, being referred to herein
as the &ldquo;<U>Registration Statement</U>&rdquo;). Copies of the Registration Statement (including all amendments thereof and all documents
deemed incorporated by reference therein) and of the related Base Prospectus have heretofore been delivered by the Company or are otherwise
available to the Underwriters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">If the Company has filed an
abbreviated registration statement to register additional Shares pursuant to Rule 462(b) under the Rules (the &ldquo;<U>462(b) Registration
Statement</U>&rdquo;), then any reference herein to the Registration Statement shall also be deemed to include such 462(b) Registration
Statement. The term &ldquo;<U>Preliminary Prospectus</U>&rdquo; means the Base Prospectus, together with any preliminary prospectus supplement
used or filed with the Commission pursuant to Rule&nbsp;424 of the Rules, in the form provided to the Underwriters by the Company for
use in connection with the offering of the Shares. The term &ldquo;<U>Prospectus</U>&rdquo; means the Base Prospectus together with any
final prospectus supplement filed pursuant to Rule 424 of the Rules in connection with the proposed sale of the Shares contemplated by
this Agreement. The term &ldquo;<U>Effective Date</U>&rdquo; shall mean each date that the Registration Statement and any post-effective
amendment or amendments thereto became or become effective. Unless otherwise stated herein, any reference herein to the Registration Statement,
any Preliminary Prospectus, the Statutory Prospectus (as hereinafter defined) and the Prospectus shall be deemed to refer to and include
the documents incorporated by reference therein, including pursuant to Item&nbsp;12 of Form S-3 under the Securities Act, which were filed
under the Securities Exchange Act of 1934, as amended (the &ldquo;<U>Exchange Act</U>&rdquo;), on or before the date hereof or are so
filed hereafter. Any reference herein to the terms &ldquo;amend,&rdquo; &ldquo;amendment&rdquo; or &ldquo;supplement&rdquo; with respect
to the Registration Statement, any Preliminary Prospectus, the Statutory Prospectus or the Prospectus shall be deemed to refer to and
include any such document filed or to be filed under the Exchange Act after the date of the Registration Statement, any such Preliminary
Prospectus, Statutory Prospectus or Prospectus, as the case may be, and deemed to be incorporated therein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The Company understands that
the Underwriters propose to make a public offering of the Shares, as set forth in and pursuant to the Statutory Prospectus and the Prospectus,
as soon after the Effective Date and the date of this Agreement as the Representative deems advisable. The Company hereby confirms that
the Underwriters and dealers have been authorized to distribute or cause to be distributed each Preliminary Prospectus, and each Issuer
Free Writing Prospectus (as hereinafter defined) and are authorized to distribute the Prospectus (as from time to time amended or supplemented
if the Company furnishes amendments or supplements thereto to the Underwriters).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Sale,
Purchase, Delivery and Payment for the Shares</U>. On the basis of the representations, warranties and agreements contained in, and subject
to the terms and conditions of, this Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company agrees to issue and sell to each of the Underwriters, and each of the Underwriters agrees, severally and not jointly, to purchase
from the Company, at a purchase price of $13.63 per share (which, for the avoidance of doubt, equals 94% of the per Firm Share public
offering price) (the &ldquo;<U>Initial Price</U>&rdquo;), the number of Firm Shares set forth opposite the name of such Underwriter under
the column &ldquo;Number of Firm Shares to be Purchased from the Company&rdquo; on Schedule I to this Agreement, subject to adjustment
in accordance with Section 8 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company hereby grants to the several Underwriters an option to purchase, severally and not jointly, all or any part of the Option Shares
at the Initial Price. The number of Option Shares to be purchased by each Underwriter shall be the same percentage (adjusted by the Representative
to eliminate fractions) of the total number of Option Shares to be purchased by the Underwriters as such Underwriter is purchasing of
the Firm Shares. Such option may be exercised only to cover over-allotments in the sales of the Firm Shares by the Underwriters and may
be exercised in whole or in part at any time on or before 12:00 noon, New York City time, on the business day before the Firm Shares Closing
Date (as hereinafter defined), and from time to time thereafter within 30 days after the date of this Agreement, in each case upon written
or facsimile notice, or verbal or telephonic notice confirmed by written or facsimile notice, by the Representative to the Company no
later than 12:00 noon, New York City time, on the business day before the Firm Shares Closing Date or at least one business day before
the Option Shares Closing Date (as hereinafter defined), as the case may be, setting forth the number of Option Shares to be purchased
and the time and date (if other than the Firm Shares Closing Date) of such purchase.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payment
of the purchase price for, and delivery of, the Firm Shares, shall be made at the offices of Roth Capital Partners, LLC, 888 San Clemente
Drive, Newport Beach, CA 92660, at 10:00 a.m., New York City time, on the second business day following the date of this Agreement or,
if the Shares are priced after 4:30 p.m. New York City time as contemplated by Rule 15c6-1c under the Exchange Act, on the third business
day following the date of this Agreement or at such time on such other date, not later than ten (10) business days after the date of this
Agreement, as shall be agreed upon by the Company and the Representative (such time and date of delivery and payment are called the &ldquo;<U>Firm
Shares Closing Date</U>&rdquo;). In addition, in the event that any or all of the Option Shares are purchased by the Underwriters, payment
of the purchase price for, and delivery of, such Option Shares shall be made at the above-mentioned offices, or at such other place as
shall be agreed upon by the Representative and the Company, on each date of delivery as specified in the notice from the Representative
to the Company (such time and date of delivery and payment are called the &ldquo;<U>Option Shares Closing Date</U>&rdquo;). The Firm Shares
Closing Date and any Option Shares Closing Date are called, individually, a &ldquo;<U>Closing Date</U>&rdquo; and, together, the &ldquo;<U>Closing
Dates</U>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payment
for the Shares to be purchased on the Firm Shares Closing Date or the Option Shares Closing Date, as the case may be, shall be made by
wire transfer of same day Federal funds to an account or accounts designated in writing by the Company, against delivery to the Representative
for the respective accounts of the several Underwriters of the Shares to be purchased on such Firm Shares Closing Date or the Option Shares
Closing Date, as the case may be, with any transfer taxes payable in connection with the sale of such Shares duly paid by the Company.
Delivery of the Shares shall be made through the facilities of The Depository Trust Company (&ldquo;<U>DTC</U>&rdquo;) unless the Representative
shall otherwise instruct.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations
and Warranties of the Company</U>. The Company represents and warrants to each Underwriter as of the date hereof, as of the Firm Shares
Closing Date and as of each Option Shares Closing Date (if any), as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company meets the requirements for use of Form S-3 under the Securities Act including the registrant requirements set forth in General
Instruction I.A and the transaction requirements set forth in General Instruction I.B.1 of such form. The Company filed with the Commission
the Registration Statement on such Form S-3, including a Base Prospectus, for registration under the Securities Act of the offering and
sale of the Shares, and the Company has prepared and used a Preliminary Prospectus in connection with the offer and sale of the Shares.
When the Registration Statement or any amendment thereof or supplement thereto was or is declared effective and as of the date of the
most recent amendment to the Registration Statement, it (i) complied or will comply, in all material respects, with the requirements of
the Securities Act and the Rules and the Exchange Act and the rules and regulations of the Commission thereunder and (ii)&nbsp;did not
or will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary
to make the statements therein not misleading. When any Preliminary Prospectus was first filed with the Commission (whether filed as part
of the Registration Statement or any amendment thereto or pursuant to Rule 424 of the Rules) and when any amendment thereof or supplement
thereto was first filed with the Commission, such Preliminary Prospectus as amended or supplemented complied in all material respects
with the applicable provisions of the Securities Act and the Rules and did not or will not contain any untrue statement of a material
fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in the light
of the circumstances under which they were made, not misleading. When any Prospectus was first filed with the Commission (whether filed
as part of the Registration Statement or any amendment thereto or pursuant to Rule 424 of the Rules), when any amendment thereof or supplement
thereto was first filed with the Commission and as of the Firm Shares Closing Date and each Option Shares Closing Date (if any), such
Prospectus complied in all material respects with the applicable provisions of the Securities Act and the Rules and did not or will not
contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order
to make the statements therein, in the light of the circumstances under which they were made, not misleading. If applicable, each Preliminary
Prospectus and the Prospectus delivered to the Underwriters for use in connection with this offering was identical to the electronically
transmitted copies thereof filed with the Commission pursuant to EDGAR, except to the extent permitted by Regulation&nbsp;S-T. Notwithstanding
the foregoing, none of the representations and warranties in this paragraph 2(a) shall apply to statements in, or omissions from, the
Registration Statement, any Preliminary Prospectus or the Prospectus made in reliance upon, and in conformity with, information herein
or otherwise furnished in writing by the Representative on behalf of the several Underwriters specifically for use in the Registration
Statement, any Preliminary Prospectus or the Prospectus. With respect to the preceding sentence, the Company acknowledges and agrees that
the only information furnished in writing by the Representative on behalf of the several Underwriters for use in the Registration Statement,
any Preliminary Prospectus or the Prospectus are the statements in the 5<SUP>th</SUP> and 13<SUP>th</SUP> paragraphs and the last sentence
of the 14<SUP>th</SUP> paragraph under the caption &ldquo;Underwriting&rdquo; in the Preliminary Prospectus and the Prospectus (collectively,
the &ldquo;<U>Underwriter Information</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of the Applicable Time (as hereinafter defined), as of the Firm Shares Closing Date and as of each Option Shares Closing Date (if any),
neither (i) the General Disclosure Package (as hereinafter defined), nor (ii)&nbsp;any individual Issuer Free Writing Prospectus when
considered together with the General Disclosure Package included any untrue statement of a material fact or omitted to state any material
fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which
they were made, not misleading; provided, however, that this representation and warranty shall not apply to statements in or omissions
in the General Disclosure Package made in reliance upon and in conformity with the Underwriter Information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each Issuer Free Writing Prospectus,
including any electronic road show (including without limitation any &ldquo;bona fide electronic road show&rdquo; as defined in Rule 433(h)(5)
under the Securities Act) (each, a &ldquo;<U>Road Show</U>&rdquo;) (i) is identified in Schedule II hereto and (ii) complied when issued,
and complies, in all material respects with the requirements of the Securities Act and the Rules and the Exchange Act and the rules and
regulations of the Commission thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As used in this Section and elsewhere
in this Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&ldquo;<U>Applicable
Time</U>&rdquo; means 8:15&nbsp;a.m. (New York City time) on the date of this Underwriting Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&ldquo;<U>General
Disclosure Package</U>&rdquo; means the Statutory Prospectus and each Issuer Free Writing Prospectus identified on Schedule II hereto
as included in the General Disclosure Package, together with the price to public and number of shares offered and sold as indicated on
the cover of the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&ldquo;<U>Statutory
Prospectus</U>&rdquo; as of any time means the Preliminary Prospectus relating to the Shares together with the pricing information referred
to in Schedule III hereto immediately prior to the Applicable Time, including any document incorporated by reference therein and any prospectus
supplement deemed to be a part thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&ldquo;<U>Issuer Free
Writing Prospectus</U>&rdquo; means each &ldquo;free writing prospectus&rdquo; (as defined in Rule 405 of the Rules) prepared by or on
behalf of the Company or used or referred to by the Company in connection with the offering of the Shares, including, without limitation,
each Road Show.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Registration Statement is effective under the Securities Act and no stop order preventing or suspending the effectiveness of the Registration
Statement or suspending or preventing the use of any Preliminary Prospectus, the Prospectus or any &ldquo;free writing prospectus,&rdquo;
as defined in Rule 405 under the Rules, has been issued by the Commission and no proceedings for that purpose have been instituted or
are threatened under the Securities Act. Any required filing of any Preliminary Prospectus and/or the Prospectus and any supplement thereto
pursuant to Rule 424(b) of the Rules has been or will be made in the manner and within the time period required by such Rule 424(b) of
the Rules. Any material required to be filed by the Company pursuant to Rule 433(d) of the Rules has been or will be made in the manner
and within the time period required by such Rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
documents incorporated by reference in the Registration Statement, any Preliminary Prospectus and the Prospectus, at the time they became
effective or were filed with the Commission, as the case may be, complied in all material respects with the requirements of the Securities
Act or the Exchange Act, as applicable, and the rules and regulations of the Commission thereunder, and, at the time such documents became
effective or were filed with the Commission, as the case may be, none of such documents contained an untrue statement of a material fact
or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of
the circumstances under which they were made, not misleading, and any further documents so filed and incorporated by reference in the
Registration Statement, any Preliminary Prospectus and the Prospectus, when such documents become effective or are filed with the Commission,
as the case may be, will conform in all material respects to the requirements of the Securities Act or the Exchange Act, as applicable,
and the rules and regulations of the Commission thereunder and will not contain an untrue statement of a material fact or omit to state
a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which
they are made, not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Issuer Free Writing Prospectus, if any, as of its issue date and at all subsequent times through the completion of the public offer and
sale of the Shares or until any earlier date that the Company notified or notifies the Representative as described in the next sentence,
did not, does not and will not include any information that conflicted, conflicts or will conflict with the information contained in the
Registration Statement,&nbsp;including any document incorporated by reference therein and any prospectus supplement deemed to be a part
thereof that has not been superseded or modified, the Statutory Prospectus or the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">If at any time following issuance
of an Issuer Free Writing Prospectus there occurred or occurs an event or development as a result of which such Issuer Free Writing Prospectus
conflicted or would conflict with the information contained in the Registration Statement, the General Disclosure Package, the Statutory
Prospectus or the Prospectus or included or would include an untrue statement of a material fact or omitted or would omit to state a material
fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances prevailing
at the subsequent time, not misleading, the Company has promptly notified or will promptly notify the Representative in writing and has
promptly amended or will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct
such conflict, untrue statement or omission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
financial statements of the Company and its consolidated subsidiaries (including all notes and schedules thereto) included or incorporated
by reference in the Registration Statement, the General Disclosure Package, the Statutory Prospectus and the Prospectus (the &ldquo;<U>Company
Financial Statements</U>&rdquo;) present fairly in all material respects the financial position of the Company and its consolidated subsidiaries
at the dates indicated and the statement of operations, stockholders&rsquo; equity and cash flows of the Company and its consolidated
subsidiaries for the periods specified; and such financial statements and related schedules and notes thereto, have been prepared in conformity
with generally accepted accounting principles in the United States (&ldquo;<U>GAAP</U>&rdquo;), consistently applied throughout the periods
involved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Marcum
LLP (&ldquo;<U>Marcum</U>&rdquo;) and PricewaterhouseCoopers LLP (together with Marcum, the &ldquo;<U>Auditors</U>&rdquo; and each an
&ldquo;<U>Auditor</U>&rdquo;), whose reports are filed with the Commission as a part of the Registration Statement, the General Disclosure
Package, the Statutory Prospectus and the Prospectus are and, during the periods covered by their reports, were independent registered
public accountants as required by the Securities Act and the Rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company and each corporation, partnership, joint venture, association or other business organization controlled directly or indirectly
by the Company (each, a &ldquo;<U>subsidiary</U>&rdquo;), is duly organized, validly existing and in good standing under the laws of their
respective jurisdictions of incorporation or organization and each such subsidiary has all requisite power and authority to carry on its
business as is currently being conducted and as described in the Registration Statement, the General Disclosure Package, the Statutory
Prospectus and the Prospectus, and to own, lease and operate its properties. All of the issued and outstanding shares of capital stock
of, or other ownership interests in, each of the Company&rsquo;s subsidiaries have been duly authorized and validly issued and are fully
paid and non-assessable and are owned, directly or indirectly, by the Company, free and clear of any lien, charge, mortgage, pledge, security
interest, claim, limitation on voting rights, equity, trust or other encumbrance, preferential arrangement, defect or restriction of any
kind whatsoever except as otherwise disclosed in the Prospectus. The Company and each of its subsidiaries is duly qualified to do business
and is in good standing as a foreign corporation in each jurisdiction in which the nature of the business conducted by it or location
of the assets or properties owned, leased or licensed by it requires such qualification, except for such jurisdictions where the failure
to so qualify individually or in the aggregate would not reasonably be expected to have a material adverse effect on the assets, liabilities,
properties, condition (financial or otherwise), results of operations, business or business prospects of the Company and its subsidiaries
considered as a whole (a &ldquo;<U>Material Adverse <FONT STYLE="color: windowtext">Effect</FONT></U><FONT STYLE="color: windowtext">&rdquo;);
and to the Company&rsquo;s knowledge, no proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing, or
seeking to revoke, limit or curtail, such power and authority or qualification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Registration Statement initially became effective within three years of the date hereof. If, immediately prior to the third anniversary
of the initial effective date of the Registration Statement, any of the Shares remain unsold by the Underwriters, the Company will, prior
to that third anniversary, file, if it has not already done so and is eligible to do so, a new &ldquo;shelf&rdquo; registration statement
relating to the Shares, in a form reasonably satisfactory to the Representative, will use its commercially reasonable efforts to cause
such registration statement to be declared effective within 180&nbsp;days after that third anniversary, and will take all other action
necessary or appropriate to permit the public offering and sale of the Shares to continue as contemplated in the expired Registration
Statement. References herein to the registration statement relating to the Shares shall include such new shelf registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company and each of its subsidiaries has all requisite corporate power and authority, and all necessary authorizations, approvals, consents,
orders, licenses, certificates and permits of and from all governmental or regulatory bodies or any other person or entity (collectively,
the &ldquo;<U>Permits</U>&rdquo;), to own, lease and license its assets and properties and conduct its business, including as described
in the Registration Statement, the General Disclosure Package, the Statutory Prospectus and the Prospectus, all of which are valid and
in full force and effect, except where the lack of such Permits, individually or in the aggregate, would not have a Material Adverse Effect.
The Company and each of its subsidiaries has fulfilled and performed in all material respects all of its obligations with respect to such
Permits and no event has occurred that allows, or after notice or lapse of time would allow, revocation or termination thereof or result
in any other material impairment of the rights of such entity thereunder. Except as may be required under the Securities Act and state
and foreign Blue Sky laws and as required by FINRA and the Nasdaq Global Market, no other Permits are required to enter into, deliver
and perform this Agreement and to issue and sell the Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)
At the earliest time after the filing of the Registration Statement that the Company or another offering participant made a <I>bona fide</I>
offer (within the meaning of Rule&nbsp;164(h)(2) of the Rules) for the Shares and (ii) at the date hereof, the Company was not and is
not an &ldquo;ineligible issuer,&rdquo; as defined in Rule&nbsp;405 of the Rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company and each of its subsidiaries has good and marketable title to all real property, and good and valid title to all other material
property owned by it, in each case free and clear of all liens, encumbrances, claims, security interests and defects, except such as do
not materially interfere with the use made or proposed to be made of such property by the Company and its subsidiaries or as are disclosed
in the Prospectus. All property held under lease by the Company and its subsidiaries is held by them under valid, existing and enforceable
leases, free and clear of all liens, encumbrances, claims, security interests and defects, except such as do not materially interfere
with the use made or proposed to be made of such property by the Company and its subsidiaries or as are disclosed in the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company and each of its subsidiaries owns or possesses adequate rights or licenses to use all material trademarks, trade names, service
marks, service mark registrations, service names, patents, patent rights, copyrights, original works, inventions, licenses, approvals,
governmental authorizations, trade secrets and other intellectual property rights and all applications and registrations therefor (&ldquo;<U>Intellectual
Property Rights</U>&rdquo;) necessary to conduct their respective businesses as now conducted and as presently proposed to be conducted.
The Company has no knowledge of any infringement by the Company or any of its subsidiaries of Intellectual Property Rights of others.
Except as disclosed in the Registration Statement, the General Disclosure Package, the Statutory Prospectus and the Prospectus, there
is no material claim, action or proceeding made or brought, or to the knowledge of the Company or any of its subsidiaries, threatened,
against the Company or any of its subsidiaries regarding the infringement of Intellectual Property Rights. The Company is not aware of
any facts or circumstances which might give rise to a claim, action or proceeding regarding the foregoing. The Company and each of its
subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and value of all of their Intellectual Property
Rights which are materially necessary to conduct their respective businesses as now conducted or as planned to be conducted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subsequent
to the respective dates as of which information is given in the Registration Statement, the General Disclosure Package, the Statutory
Prospectus and the Prospectus, (i) there has not been any event which would reasonably be expected to have a Material Adverse Effect;
(ii) neither the Company nor any of its subsidiaries has sustained any material loss or interference with its assets, businesses or properties
(whether owned or leased) from fire, explosion, earthquake, flood or other calamity, whether or not covered by insurance, or from any
labor dispute or any court or legislative or other governmental action, order or decree; and (iii) since the date of the latest balance
sheet included in the Registration Statement, the General Disclosure Package, the Statutory Prospectus and the Prospectus, neither the
Company nor any of its subsidiaries has (A) except as disclosed in the Registration Statement, the General Disclosure Package, the Statutory
Prospectus and the Prospectus, issued any securities other than equity awards made pursuant to the Company&rsquo;s 2014 Equity Incentive
Plan or the vesting of restricted stock awards or units or the exercise of options pursuant to the Company&rsquo;s 2014 Equity Incentive
Plan or 2005 Equity Incentive Plan (collectively, the &ldquo;<U>Plans</U>&rdquo;), or incurred any liability or obligation, direct or
contingent, for borrowed money, except such liabilities or obligations (including borrowings under the Company&rsquo;s revolving credit
facility) incurred in the ordinary course of business consistent with past practice, (B) entered into any material transaction not in
the ordinary course of business or (C) declared or paid any dividend or made any distribution on any shares of its stock or redeemed,
purchased or otherwise acquired or agreed to redeem, purchase or otherwise acquire any shares of its capital stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(o)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There
is no document, contract or other agreement required to be described in the Registration Statement, the General Disclosure Package, the
Statutory Prospectus or the Prospectus or to be filed as an exhibit to the Registration Statement which is not described or filed as required
by the Securities Act or Rules. Each description of a contract, document or other agreement in the Registration Statement, the General
Disclosure Package, the Statutory Prospectus or the Prospectus accurately reflects in all material respects the terms of the underlying
contract, document or other agreement. Neither the Company nor any of its subsidiaries, if a subsidiary is a party, nor to the Company&rsquo;s
knowledge, any other party is in default in the observance or performance of any material term or obligation to be performed by it under
any contract, document or other agreement described in the Registration Statement, the General Disclosure Package, the Statutory Prospectus
or the Prospectus or listed in the Exhibits to the Registration Statement or incorporated by reference, and no event has occurred which
with notice or lapse of time or both would constitute such a default. No default exists, and no event has occurred which with notice or
lapse of time or both would constitute a default, in the due performance and observance of any term, covenant or condition, by the Company
or any of its subsidiaries, if a subsidiary is a party thereto, of any other agreement or instrument to which the Company or any of its
subsidiaries is a party or by which the Company or its properties or business or any subsidiary or its properties or business may be bound
or affected which default or event, individually or in the aggregate, would reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(p)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
statistical and market related data included in the Registration Statement, the General Disclosure Package, the Statutory Prospectus or
the Prospectus are based on or derived from sources that the Company believes to be reliable and accurate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(q)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither
the Company nor any subsidiary (i) is in violation of its certificate or articles of incorporation, bylaws, certificate of formation,
limited liability company agreement, partnership agreement or other organizational documents, (ii) is in default under (except for such
defaults as have been waived), and no event has occurred which, with notice or lapse of time, or both, would constitute a default under,
or result in the creation or imposition of any lien, charge, mortgage, pledge, security interest, claim, limitation on voting rights,
equity, trust or other encumbrance, preferential arrangement, defect or restriction of any kind whatsoever, upon, any property or assets
of the Company or any subsidiary pursuant to, any bond, debenture, note, indenture, mortgage, deed of trust, loan agreement or other agreement
or instrument to which it is a party or by which it is bound or to which any of its properties or assets is subject or (iii) is in violation
of any statute, law, rule, regulation, ordinance, directive, judgment, decree or order of any judicial, regulatory or other legal or governmental
agency or body, foreign or domestic, except (in the case of clauses (ii) and (iii) above) for defaults, events or violations that would
not (individually or in the aggregate) reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(r)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
Agreement has been duly authorized, executed and delivered by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(s)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as disclosed on the Disclosure Schedule, neither the execution, delivery and performance of this Agreement by the Company nor the consummation
of any of the transactions contemplated hereby, including, without limitation, the issuance and sale by the Company of the Shares, will
give rise to a right to terminate or accelerate the due date of any payment due under, or conflict with or result in the breach of any
term or provision of, or constitute a default (or an event which with notice or lapse of time or both would constitute a default) under,
or require any consent or waiver under, or result in the execution or imposition of any lien, charge or encumbrance upon any properties
or assets of the Company or its subsidiaries pursuant to the terms of, any bond, debenture, note, indenture, mortgage, deed of trust or
other agreement or instrument to which the Company or any of its subsidiaries is a party or by which either the Company or any of its
subsidiaries or any of their properties or businesses is bound, or any franchise, license, permit, judgment, decree, order, statute, rule
or regulation applicable to the Company or any of its subsidiaries or violate any provision of the certificate or articles of incorporation
or bylaws of the Company or any of its subsidiaries, except for such consents or waivers which have already been obtained and are in full
force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(t)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company has authorized and outstanding capital stock as set forth in the Statutory Prospectus and the Prospectus. All of the issued and
outstanding shares of Common Stock have been duly authorized and validly issued and are fully paid and non-assessable. There are no statutory
preemptive or other similar rights to subscribe for or to purchase or acquire any shares of Common Stock of the Company or any of its
subsidiaries or any such rights pursuant to its Certificate of Incorporation, as amended, or Amended and Restated By-laws or any agreement
or instrument to or by which the Company or any of its subsidiaries is a party or bound. The Shares to be sold by the Company have been
duly authorized and, when issued and sold pursuant to this Agreement will be duly authorized and validly issued, fully paid and non-assessable,
free and clear of any lien or encumbrance of any kind, and none of them will be subject to, or issued in violation of, any preemptive
or other similar right. Except as disclosed in the Registration Statement, the General Disclosure Package, the Statutory Prospectus and
the Prospectus, there is no outstanding option, warrant or other right (other than those issued pursuant to the Plans in the ordinary
course of business) calling for the issuance of, and there is no commitment, plan or arrangement to issue, any share of capital stock
of the Company or any of its subsidiaries or any security convertible into, or exercisable or exchangeable for, such stock. The exercise
price of each option to acquire Common Stock (each, a &ldquo;<U>Company Stock Option</U>&rdquo;) is no less than the fair market value
of a share of Common Stock as determined on the date of grant of such Company Stock Option. All grants of Company Stock Options, stock
appreciation rights and restricted stock awards were validly issued and duly authorized and approved by the Board of Directors of the
Company (or committees thereof) in compliance with all applicable laws and the terms of the plan under which such Company Stock Options,
stock appreciation rights and restricted stock awards were issued and were recorded on the Company Financial Statements in accordance
with GAAP, and no such grants involved any &ldquo;back dating,&rdquo; &ldquo;forward dating,&rdquo; &ldquo;spring loading&rdquo; or similar
practices with respect to the effective date of grant. The Common Stock and the Shares conform in all material respects to all statements
in relation thereto contained in the Registration Statement, the General Disclosure Package, the Statutory Prospectus and the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(u)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
holder of any security of the Company has any right, which has not been waived, to have any security owned by such holder included in
the Registration Statement or included in the offering contemplated by this Agreement. Each director and executive officer of the Company
listed on Schedule IV hereto has delivered to the Representative an enforceable written lock-up agreement substantially in the form attached
to this Agreement as Exhibit A hereto (&ldquo;<U>Lock-Up Agreement</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There
are no legal or governmental proceedings pending to which the Company or any of its subsidiaries is a party or of which any property of
the Company or any of its subsidiaries is the subject which would have a Material Adverse Effect; and, to the knowledge of the Company,
no such proceedings are threatened or contemplated by governmental authorities or threatened by others.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(w)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
necessary corporate action has been duly and validly taken by the Company to authorize the execution, delivery and performance of this
Agreement and the issuance and sale of the Shares by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither
the Company nor any of its subsidiaries is involved in any labor dispute and, to the knowledge of the Company, is any such dispute threatened,
in each case as would reasonably be expected to have a Material Adverse Effect. The Company is not aware of any existing or imminent labor
disturbance by the employees of any of its principal suppliers or contractors which would be material to the Company and its subsidiaries
taken as a whole. The Company is not aware of any threatened or pending litigation between the Company or its subsidiaries and any of
its executive officers which would have a Material Adverse Effect and has no reason to believe that such officers will not remain in the
employment of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(y)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
transaction has occurred between or among the Company and any of its officers or directors, stockholders or any affiliate or affiliates
of any such officer or director or stockholder that is required to be described in and is not described in the Registration Statement,
the General Disclosure Package, the Statutory Prospectus and the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(z)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company has not taken, nor will it take, directly or indirectly, any action designed to or which would reasonably be expected to cause
or result in, or which has constituted or which would reasonably be expected to constitute, the stabilization or manipulation of the price
of the Common Stock or any security of the Company to facilitate the sale or resale of any of the Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(aa)&#9;&nbsp;&nbsp;&nbsp;&nbsp;The Company and each
of its subsidiaries has filed (or filed an extension of time within which to file) all Federal, state, local and foreign tax returns which
are required to be filed through the date hereof, which returns are true and correct in all material respects or has received timely extensions
thereof, and has paid all taxes shown on such returns and all assessments received by it to the extent that the same have become due.
There are no tax audits or investigations pending, which would have a Material Adverse Effect; nor are there any material proposed additional
tax assessments against the Company or any of its subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(bb)&#9;&nbsp;&nbsp;&nbsp;&nbsp;The Company has taken
no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or listing
on the Nasdaq Global Market, nor has the Company received any notification that the Commission or the Nasdaq Global Market is contemplating
terminating such registration or listing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(cc)&#9;&nbsp;&nbsp;&nbsp;&nbsp;The books, records and
accounts of the Company and its subsidiaries accurately and fairly reflect all material transactions in, and dispositions of, the assets
of, and the liabilities and results of operations of, the Company and its subsidiaries. The Company and each of its subsidiaries maintains
a system of internal accounting controls sufficient to provide reasonable assurances that (i) transactions are executed in accordance
with management&rsquo;s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial
statements in accordance with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management&rsquo;s
general or specific authorization, and (iv) the recorded accountability for assets is compared with the existing assets at reasonable
intervals and appropriate action is taken with respect to any differences.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(dd)&#9;&nbsp;&nbsp;&nbsp;The interactive data
in eXtensible Business Reporting Language included or incorporated by reference in the Registration Statement, if any, fairly presents
the information called for in all material respects and has been prepared in accordance with the Commission&rsquo;s rules and guidelines
applicable thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ee)&#9;&nbsp;&nbsp;&nbsp;&nbsp;Except as disclosed
in the Registration Statement, the General Disclosure Package, the Statutory Prospectus and the Prospectus, the Company has established
and maintains disclosure controls and procedures (as such term is defined in Rule 13a-15 under the Exchange Act), which: (i) are designed
to ensure that material information relating to the Company and its subsidiaries is made known to the Company&rsquo;s principal executive
officer and its principal financial officer by others within the Company, particularly during the periods in which the periodic reports
required under the Exchange Act are required to be prepared; (ii) provide for the periodic evaluation of the effectiveness of such disclosure
controls and procedures at the end of the periods in which the periodic reports are required to be prepared; and (iii) are effective in
all material respects to perform the functions for which they were established.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ff)&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based on the evaluation
of its disclosure controls and procedures as of the most recent evaluation date, except as disclosed in the Registration Statement, the
General Disclosure Package, the Statutory Prospectus and the Prospectus, the Company is not aware of (i) any material weakness or significant
deficiency in the design or operation of internal controls which would reasonably be expected to adversely affect the Company&rsquo;s
or any subsidiary&rsquo;s ability to record, process, summarize and report financial data or any material weaknesses in internal controls;
or (ii) any fraud, whether or not material, that involves management or other employees who have a role in the Company&rsquo;s or its
subsidiaries&rsquo; internal controls.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(gg)&#9;&nbsp;&nbsp;&nbsp;&nbsp;Except as described
in the Statutory Prospectus and the Prospectus and as preapproved in accordance with the requirements set forth in Section 10A of the
Exchange Act, PwC was not, and Marcum has not been, engaged by the Company to perform any &ldquo;prohibited activities&rdquo; (as defined
in Section 10A of the Exchange Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(hh)&#9;&nbsp;&nbsp;&nbsp;&nbsp;Except as described
in the Statutory Prospectus and the Prospectus, there are no material off-balance sheet arrangements (as defined in Item 303 of Regulation
S-K) that have or are reasonably likely to have a material current or future effect on the financial condition, revenues or expenses,
changes in financial condition, results of operations, liquidity, capital expenditures or capital resources of the Company and its subsidiaries
taken as a whole.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company&rsquo;s board of directors has validly appointed an audit committee whose composition satisfies the requirements of the Nasdaq
Global Market and the audit committee has adopted a charter that satisfies the requirements of the Nasdaq Global Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(jj)&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There is and has been
no failure on the part of the Company or any of its directors or officers, in their capacities as such, to comply with any provision of
the Sarbanes-Oxley Act, including, without limitation, Section 402 related to loans and Sections 302 and 906 related to certifications.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(kk)&#9;&nbsp;&nbsp;&nbsp;&nbsp;The Company and its
subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as the Company
reasonably believes is appropriate in the businesses in which they are engaged or propose to engage after giving effect to the matters
described in the Statutory Prospectus and the Prospectus; all policies of insurance and fidelity or surety bonds insuring the Company
or any of its subsidiaries or the Company&rsquo;s or its subsidiaries&rsquo; respective businesses, operations, assets, employees, officers
and directors are in full force and effect; the Company and each of its subsidiaries are in compliance with the terms of such policies
and instruments in all material respects; and neither the Company nor any subsidiary of the Company has any reason to believe that it
will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar
insurers as may be necessary to continue its business at a cost that is not materially greater than the current cost. Neither the Company
nor any of its subsidiaries has been denied any material insurance coverage which it has sought or for which it has applied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ll)&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each approval, consent,
order, authorization, designation, declaration or filing of, by or with any regulatory, administrative or other governmental body necessary
in connection with the execution and delivery by the Company of this Agreement and the consummation of the transactions herein and therein
contemplated required to be obtained or performed by the Company has been obtained or made and is in full force and effect, except for
such filings as may be required to be made on or after the date hereof under federal or state securities or Blue Sky laws or under the
rules and regulations of the Financial Industry Regulatory Authority, Inc. (&ldquo;<U>FINRA</U>&rdquo;) in connection with the offer and
sale of the Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(mm)&#9;&nbsp;&nbsp;To the knowledge of
the Company, there are no affiliations with FINRA among the Company&rsquo;s officers, directors or any five percent or greater stockholder
of the Company, except as set forth in the Registration Statement, the General Disclosure Package, the Statutory Prospectus or the Prospectus
or otherwise disclosed in writing to the Representative prior to the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(nn)&#9;&nbsp;&nbsp;&nbsp;&nbsp;The Company is not a
passive foreign investment company (&ldquo;<U>PFIC</U>&rdquo;) within the meaning of Section&nbsp;1297 of the United States Internal Revenue
Code of 1986, as amended, and, to the Company&rsquo;s knowledge, does not expect to become a PFIC for the year ending December 31, 2021
or any future year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(oo)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)
Each of the Company and each of its subsidiaries is in compliance in all material respects with all rules, laws and regulation relating
to the use, treatment, storage and disposal of toxic substances and protection of health or the environment (&ldquo;<U>Environmental Laws</U>&rdquo;)
which are applicable to its business; (ii) neither the Company nor its subsidiaries has received any notice from any governmental authority
or third party of an asserted claim under Environmental Laws; (iii) each of the Company and each of its subsidiaries has received all
material permits, licenses or other approvals required of it under applicable Environmental Laws to conduct its business and is in material
compliance with all terms and conditions of any such permit, license or approval; (iv) to the Company&rsquo;s knowledge, no facts currently
exist that will require the Company or any of its subsidiaries to make future material capital expenditures to comply with Environmental
Laws; and (v) no property which is or has been owned, leased or occupied by the Company or its subsidiaries has been designated as a Superfund
site pursuant to the Comprehensive Environmental Response, Compensation of Liability Act of 1980, as amended (42 U.S.C. Section 9601,
et. seq.) (&ldquo;<U>CERCLA</U>&rdquo;) or otherwise designated as a contaminated site under applicable state or local law. Neither the
Company nor any of its subsidiaries has been named as a &ldquo;potentially responsible party&rdquo; under CERCLA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(pp)&#9;&nbsp;&nbsp;&nbsp;&nbsp;The Company has reasonably
concluded there are no costs and liabilities associated with Environmental Laws applicable to the Company and its subsidiaries, (including,
without limitation, any capital or operating expenditures required for clean-up, closure of properties or compliance with Environmental
Laws, or any permit, license or approval, any related constraints on operating activities and any potential liabilities to third parties)
that would reasonably be expected to be material to the Company and its subsidiaries taken as a whole.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(qq)&#9;&nbsp;&nbsp;&nbsp;&nbsp;The Company is not and,
after giving effect to the offering and sale of the Shares and the application of proceeds thereof as described in the Statutory Prospectus
and the Prospectus, will not be an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended
(the &ldquo;<U>Investment Company Act</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(rr)&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither the Company
nor any subsidiary or, to the knowledge of the Company, any other person associated with or acting on behalf of the Company or any subsidiary
including, without limitation, any director, officer, agent or employee of the Company or its subsidiaries, has, directly or indirectly,
while acting on behalf of the Company or its subsidiaries (i) used any corporate funds for unlawful contributions, gifts, entertainment
or other unlawful expenses relating to political activity; (ii)&nbsp;made any unlawful payment to foreign or domestic government officials
or employees or to foreign or domestic political parties or campaigns from corporate funds; (iii) violated any provision of the Foreign
Corrupt Practices Act of 1977, as amended; or (iv) made any other unlawful payment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ss)&#9;&nbsp;&nbsp;&nbsp;&nbsp;The operations of the
Company and its subsidiaries are and have been conducted at all times in compliance with applicable financial recordkeeping and reporting
requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering statutes of all jurisdictions,
the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by
any governmental agency (collectively, the &ldquo;<U>Money Laundering Laws</U>&rdquo;) and no action, suit or proceeding by or before
any court or governmental agency, authority or body or any arbitrator involving the Company or any of its subsidiaries with respect to
the Money Laundering Laws is pending, or to the knowledge of the Company, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(tt)&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither the Company
nor any of its subsidiaries nor, to the knowledge of the Company, any director, officer, agent, employee or affiliate of the Company or
any of its subsidiaries is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury
Department (&ldquo;<U>OFAC</U>&rdquo;); and the Company will not directly or indirectly use the proceeds of the offering, or lend, contribute
or otherwise make available such proceeds to any subsidiary, joint venture partner or other person or entity, for the purpose of financing
the activities of any person currently subject to any U.S. sanctions administered by OFAC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(uu)&#9;&nbsp;&nbsp;&nbsp;&nbsp;Except as described
in the Statutory Prospectus and the Prospectus, the Company has not sold or issued any shares of capital stock during the six-month period
preceding the date of the Prospectus, including any sales pursuant to Rule 144A under, or Regulations D or S of, the Securities Act, other
than shares issued pursuant to employee benefit plans, qualified stock options plans or other employee compensation plans or pursuant
to outstanding options, rights or warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(vv)&#9;&nbsp;&nbsp;&nbsp;&nbsp;The Company has fulfilled
its obligations, if any, under the minimum funding standards of Section 302 of the U.S. Employee Retirement Income Security Act of 1974
(&ldquo;<U>ERISA</U>&rdquo;) and the regulations and published interpretations thereunder with respect to each &ldquo;plan&rdquo; as defined
in Section 3(3) of ERISA and such regulations and published interpretations in which its employees are eligible to participate and each
such plan is in compliance in all material respects with the presently applicable provisions of ERISA and such regulations and published
interpretations. No &ldquo;Reportable Event&rdquo; (as defined in ERISA) has occurred with respect to any &ldquo;Pension Plan&rdquo; (as
defined in ERISA) for which the Company could have any liability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ww)&#9;&nbsp;&nbsp;&nbsp;The Company and its
subsidiaries&rsquo; information technology assets and equipment, computers, systems, networks, hardware, software, websites, applications
and databases (collectively, &ldquo;<U>IT Systems</U>&rdquo;) are adequate for, and operate and perform in all material respects as required
in connection with the operation of the business of the Company and its subsidiaries as currently conducted, free and clear of all material
bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants. The Company and its subsidiaries have implemented and
maintained commercially reasonable controls, policies, procedures, and safeguards to maintain and protect their material confidential
information and the integrity, continuous operation, redundancy and security of all IT Systems and data (including all personal, personally
identifiable, sensitive, confidential or regulated data (&ldquo;<U>Personal Data</U>&rdquo;)) used in connection with their businesses,
and there have been no breaches, violations, outages or unauthorized uses of or accesses to same, except for those that have been remedied
without material cost or liability or the duty to notify any other person, nor any incidents under internal review or investigations relating
to the same. The Company and its subsidiaries are presently in material compliance with all applicable laws or statutes and all judgments,
orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations
relating to the privacy and security of IT Systems and Personal Data and to the protection of such IT Systems and Personal Data from unauthorized
use, access, misappropriation or modification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(xx)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None
of the Company, its directors or its officers has distributed nor will distribute prior to the later of (i) the Firm Shares Closing Date,
or the Option Shares Closing Date, and (ii) completion of the distribution of the Shares, any offering material in connection with the
offering and sale of the Shares other than any Preliminary Prospectus, the Prospectus, the Registration Statement and other materials,
if any, permitted by the Securities Act and consistent with Section 4(a) below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(yy)&#9; &nbsp;&nbsp;Without limiting
any of the other representations and warranties contained in this Agreement, the Company and each of its subsidiaries have not
violated in any material respect and are in compliance in all material respects with all applicable laws. Neither the Company nor
any of its subsidiaries has received any notice to the effect that, or otherwise been advised that, it is not in material compliance
with any applicable laws, and the Company has no reason to anticipate that any existing circumstances are reasonably likely to
result in a material violation of any applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Conditions
of the Underwriters&rsquo; Obligations</U>. The obligations of the Underwriters under this Agreement are several and not joint. The respective
obligations of the Underwriters to purchase the Shares are subject to each of the following terms and conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notification
that the Registration Statement has become effective shall have been received by the Representative and the Prospectus shall have been
timely filed with the Commission in accordance with Section 4(a) of this Agreement and any material required to be filed by the Company
pursuant to Rule 433(d) of the Rules shall have been timely filed with the Commission in accordance with such rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
order preventing or suspending the use of any Preliminary Prospectus, the Prospectus or any &ldquo;free writing prospectus&rdquo; (as
defined in Rule 405 of the Rules) shall have been or shall be in effect and no order suspending the effectiveness of the Registration
Statement shall be in effect and no proceedings for such purpose shall be pending before or threatened by the Commission, and any requests
for additional information on the part of the Commission (to be included in the Registration Statement or the Prospectus or otherwise)
shall have been complied with to the satisfaction of the Commission and the Representative. If the Company has elected to rely upon Rule
430A, information previously omitted from the effective Registration Statement pursuant to Rule 430A shall have been transmitted to the
Commission for filing pursuant to Rule 424(b) within the prescribed time period and the Company shall have provided evidence satisfactory
to the Representative of such timely filing, or a post-effective amendment providing such information shall have been promptly filed and
declared effective in accordance with the requirements of Rule 430A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
representations and warranties of the Company contained in this Agreement shall be true and correct, and the representations and warranties
of the Company contained in the certificates delivered pursuant to Section 3(d) shall be true and correct in all material respects, when
made and on and as of each Closing Date as if made on such date (provided, that each representation and warranty that contains a materiality
qualifier shall be true and correct in all respects as of such Closing Date). The Company shall have performed all covenants and agreements
and satisfied all the conditions contained in this Agreement required to be performed or satisfied by it at or before such Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Representative shall have received on each Closing Date a certificate, addressed to the Underwriters and dated such Closing Date, of the
chief executive officer and the chief financial officer or chief accounting officer of the Company to the effect that: (i) the representations,
warranties and agreements of the Company in this Agreement were true and correct when made and are true and correct in all material respects
as of such Closing Date (provided, that each representation and warranty that contains a materiality qualifier shall be true and correct
in all respects as of such Closing Date); (ii) the Company has performed all covenants and agreements and satisfied all conditions contained
herein; (iii) they have carefully examined the Registration Statement, the Prospectus, the General Disclosure Package, and any individual
Issuer Free Writing Prospectus and, in their opinion (A) (1) as of the Effective Date, the Registration Statement did not or will not
contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order
to make the statements therein not misleading, (2) as of the date thereof or as of the date hereof, the Prospectus did not contain and
does not contain any untrue statement of a material fact or omitted to state a material fact necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading, and (3) as of the Applicable Time, neither (<I>x</I>)&nbsp;the
General Disclosure Package, nor (<I>y</I>)&nbsp;any individual Issuer Free Writing Prospectus, when considered together with the General
Disclosure Package, included any untrue statement of a material fact or omitted to state a material fact required to be stated therein
or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading, and
(B) since the Effective Date, no event has occurred which should have been set forth in a supplement or otherwise required an amendment
to the Registration Statement, the Statutory Prospectus or the Prospectus; (iv) no stop order suspending the effectiveness of the Registration
Statement has been issued and, to their knowledge, no proceedings for that purpose have been instituted or are pending under the Securities
Act and (v) there has not occurred since the date of this Agreement any material adverse change in the assets, liabilities, properties,
condition (financial or otherwise), or in the results of operations, business or business prospects of the Company and its subsidiaries
considered as a whole.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Representative shall have received: (i) simultaneously with the execution of this Agreement a signed letter from each of the Auditors
addressed to the Underwriters and dated the date of this Agreement, in form and substance reasonably satisfactory to the Representative,
containing statements and information of the type ordinarily included in accountants&rsquo; &ldquo;comfort letters&rdquo; to underwriters
with respect to the financial statements and certain financial information contained in the Registration Statement and the General Disclosure
Package, and (ii) on each Closing Date, a signed letter from each of the Auditors addressed to the Representative and dated the date of
such Closing Date(s), in form and substance reasonably satisfactory to the Representative containing statements and information of the
type ordinarily included in accountants&rsquo; &ldquo;comfort letters&rdquo; to underwriters with respect to the financial statements
and certain financial information contained in the Registration Statement and the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Representative shall have received on each Closing Date from Day Pitney LLP, counsel for the Company, an opinion and negative assurance
letter, addressed to the Underwriters and dated such Closing Date, substantially in the form attached hereto as Exhibit B (which shall
be subject to customary assumptions, exceptions, limitations and qualifications).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Representative shall have received on each Closing Date from Pillsbury Winthrop Shaw Pittman LLP, counsel for the Underwriters, an opinion,
addressed to the Representative and dated such Closing Date, with respect to such matters as the Representative may reasonably require,
and the Company shall have furnished or provided access to such counsel such documents as they request for enabling them to pass upon
such matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
proceedings taken in connection with the sale of the Firm Shares and the Option Shares as herein contemplated shall be reasonably satisfactory
in form and substance to the Representative and its counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Representative shall have received copies of the Lock-up Agreements executed by each entity or person listed on Schedule IV hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Shares shall have been approved for listing on the Nasdaq Global Market, subject only to official notice of issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Representative shall be reasonably satisfied that since the respective dates as of which information is given in the Registration Statement,
the Statutory Prospectus, the General Disclosure Package and the Prospectus (i) there shall not have been any material change in the
capital stock of the Company or any subsidiary or any material change in the indebtedness of the Company or any of its subsidiaries,
(ii) except as set forth or contemplated by the Registration Statement, the Statutory Prospectus, the General Disclosure Package or the
Prospectus, no material oral or written agreement or other transaction shall have been entered into by the Company or its subsidiaries
that is not in the ordinary course of business or that would reasonably be expected to result in a material reduction in the future earnings
of the Company, (iii) no loss or damage (whether or not insured) to the property of the Company or any subsidiary shall have been sustained
that had or would reasonably be expected to have a Material Adverse Effect, (iv) no legal or governmental action, suit or proceeding
affecting the Company, any of its subsidiaries or any of their respective properties that is material to the Company or any of its subsidiaries
or that affects or would reasonably be expected to affect the transactions contemplated by this Agreement shall have been instituted
or threatened and (v) there shall not have been any material change in the assets, liabilities, properties, condition (financial or otherwise),
or in the results of operations, business or business prospects of the Company or its subsidiaries considered as a whole that makes it
impractical or inadvisable in the Representative&rsquo;s judgment to proceed with the purchase or offering of the Shares as contemplated
hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Representative shall have received (i) simultaneously with the execution of this Agreement a certificate, addressed to the Underwriters
and dated the date of this Agreement, of the chief financial officer of the Company addressed to the Underwriters, in form and substance
reasonably satisfactory to the Representative, with respect to certain information contained in the Registration Statement and the General
Disclosure Package and (ii) on each Closing Date, a certificate of the chief financial officer of the Company addressed to the Underwriters,
in form and substance reasonably satisfactory to the Representative, with respect to certain information contained in the Registration
Statement and the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall have furnished or caused to be furnished to the Representative such further certificates or documents as the Representative
shall have reasonably requested.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">If any condition specified in
this Section shall not have been fulfilled when and as required to be fulfilled, this Agreement, and the obligation of the Underwriters
to purchase the Firm Shares or Option Shares, as the case may be, may be terminated by the Representative by written notice to the Company
at any time at or prior to the Closing Date, and, except for an intentional or willful breach of this Agreement, such termination shall
be without liability of any party to any other party, except as provided in Section 4(b); provided, however, that Sections 4(b), 5, 6,
7 and 9 shall survive any such termination and remain in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Covenants
and other Agreements of the Company and the Underwriters</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">The Company covenants and agrees as follows:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company will use its reasonable best efforts to cause the Registration Statement, if not effective at the time of execution of this Agreement,
and any amendments thereto, to become effective as promptly as possible. The Company shall prepare the Preliminary Prospectus and Prospectus
in a form approved by the Representative (such approval not to be unreasonably withheld or delayed) and file such Prospectus pursuant
to Rule 424(b) under the Securities Act not later than the Commission&rsquo;s close of business on the second business day following the
execution and delivery of this Agreement, or, if applicable, such earlier time as may be required by the Rules. The Company will file
with the Commission all Issuer Free Writing Prospectuses in the time and manner required under Rules 433(d) or 163(b)(2), as the case
may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During
the period beginning on the date hereof and ending on the later of the Closing Date or such date as reasonably determined by the Representative
the Prospectus is no longer required by law to be delivered in connection with sales by an underwriter or dealer (the &ldquo;<U>Prospectus
Delivery Period</U>&rdquo;), the Company shall promptly advise the Representative in writing (A) when any post-effective amendment to
the Registration Statement shall have become effective, or any supplement to the Prospectus shall have been filed, (B) of any request
by the Commission for any amendment of the Registration Statement or the Prospectus or for any additional information, (C) of the issuance
by the Commission of any stop order suspending the effectiveness of the Registration Statement or of any order preventing or suspending
the use of any preliminary prospectus or any &ldquo;free writing prospectus,&rdquo; as defined in Rule 405 of the Rules, or the institution
or threatening of any proceeding for that purpose and (D) of the receipt by the Company of any notification with respect to the suspension
of the qualification of the Shares for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose. During
the Prospectus Delivery Period, the Company shall not file any amendment of the Registration Statement or supplement to the Prospectus
or any document incorporated by reference in the Registration Statement or any Issuer Free Writing Prospectus unless the Company has furnished
to the Representative a copy for its review prior to filing and shall not file any such proposed amendment or supplement to which the
Representative reasonably objects. The Company shall use its reasonable best efforts to prevent the issuance of any such stop order and,
if issued, to obtain as soon as possible the withdrawal thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If,
at any time when a prospectus relating to the Shares (or, in lieu thereof, the notice referred to in Rule 173(a) of the Rules) is required
to be delivered under the Securities Act and the Rules, any event occurs as a result of which the Prospectus as then amended or supplemented
would include any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein, in
the light of the circumstances under which they were made, not misleading, or if it shall be necessary to amend or supplement the Prospectus
to comply with the Securities Act or the Rules, the Company promptly shall prepare and file with the Commission, subject to the second
sentence of paragraph (ii) of this Section 4(a), an amendment or supplement which shall correct such statement or omission or an amendment
which shall effect such compliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
at any time following issuance of an Issuer Free Writing Prospectus there occurs an event or development as a result of which such Issuer
Free Writing Prospectus would conflict with the information contained in the Registration Statement or would include an untrue statement
of a material fact or would omit to state a material fact required to be stated therein or necessary in order to make the statements therein,
in the light of the circumstances prevailing at the subsequent time, not misleading, the Company will promptly notify the Representative
and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict,
untrue statement or omission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall make generally available to its security holders and to the Representative as soon as practicable, but not later than 45
days after the end of the 12-month period beginning at the end of the fiscal quarter of the Company during which the Effective Date occurs
(or 90 days if such 12-month period coincides with the Company&rsquo;s fiscal year), an earnings statement (which need not be audited)
of the Company, covering such 12-month period, which shall satisfy the provisions of Section 11(a) of the Securities Act and Rule 158
of the Rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall furnish to the Representative and counsel for the Underwriters, without charge, signed copies of the Registration Statement
(including all exhibits thereto and amendments thereof) (if requested) and to each other Underwriter, without charge, a copy of the Registration
Statement (without exhibits thereto) (if requested) and all amendments thereof and, so long as delivery of a prospectus by an Underwriter
or dealer may be required by the Securities Act or the Rules, as many copies of any Preliminary Prospectus, any Issuer Free Writing Prospectus
and the Prospectus and any amendments thereof and supplements thereto as the Representative may reasonably request. If applicable, the
copies of the Registration Statement, Preliminary Prospectus, any Issuer Free Writing Prospectus and Prospectus and each amendment and
supplement thereto furnished to the Underwriters will be identical to the electronically transmitted copies thereof filed with the Commission
pursuant to EDGAR, except to the extent permitted by Regulation S-T.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">(vii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall cooperate with the Representative and its counsel in endeavoring to qualify the Shares for offer and sale in connection
with the offering under the laws of such jurisdictions as the Representative may designate and shall use its reasonable best efforts to
maintain such qualifications in effect so long as required for the distribution of the Shares; provided, however, that the Company shall
not be required in connection therewith, as a condition thereof, to qualify as a foreign corporation or to execute a general consent to
service of process in any jurisdiction or subject itself to taxation as doing business in any jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">(viii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company, during the period when the Prospectus (or in lieu thereof, the notice referred to in Rule 173(a) of the Rules) is required to
be delivered under the Securities Act and the Rules or the Exchange Act, will file all reports and other documents required to be filed
with the Commission pursuant to Section 13, 14 or 15 of the Exchange Act within the time periods required by the Exchange Act and the
regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">(ix)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Without
the prior written consent of the Representative, for a period of 90 days after the date of the Prospectus, the Company shall not (i) offer,
pledge, issue, sell, contract to sell, purchase, contract to purchase, lend or otherwise transfer or dispose of, directly or indirectly,
any shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock; (ii) enter into any swap
or other arrangement that transfers, in whole or in part, any of the economic consequences of ownership of shares of Common Stock; or
(iii) file any registration statement with the Commission relating to the offering of any shares of Common Stock or any securities convertible
into or exercisable or exchangeable for shares of common stock, except for: (i) the issuance of the Shares pursuant to this Agreement,
(ii) the issuance of shares pursuant to the Plans and the filing of any registration statement on Form S-8 in connection therewith; (iii)
the issuance of shares pursuant to the vesting of restricted stock awards or units pursuant to the Plans; and (iv) the issuance of shares
of Common Stock or any securities convertible into, or exercisable or exchangeable for, Common Stock, in connection with any merger or
acquisition of securities, businesses, property or other assets or strategic investment (including any joint venture, strategic alliance,
partnership, equipment leasing arrangement or debt financing) as long as the aggregate number of shares of Common Stock issued or issuable
does not exceed 5% of the number of shares outstanding immediately after the issuance and sale of the shares of Common Stock pursuant
to this Agreement and each recipient of any such shares executes and delivers to the Representative on the closing date of such acquisition
or strategic investment a Lock-Up Agreement and agrees to be bound by the restrictions contained therein during such 90-day period. The
Company represents and warrants that each director and executive officer set forth on Schedule IV hereto and each holder of five percent
(5%) or more of Common Stock as of the Applicable Time who is an affiliate of the Company shall be subject to lockup restrictions substantially
in the form set forth on Exhibit A attached hereto and covenants and agrees that it shall impose stop-transfer restrictions on any such
sale or other transfer or disposition of such shares in violation thereof until the end of the 90-day period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
or before completion of the offering, the Company shall make all filings required under applicable securities laws and by the Nasdaq Global
Market (including any required registration under the Exchange Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">(xi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prior
to the Closing Date, the Company shall not issue any press release or other communications directly or indirectly and shall not hold a
press conference with respect to the Company or its subsidiaries, or the condition (financial or otherwise) or the earnings, business
affairs or business prospects of any of them, or the offering of the Shares, without the prior written consent of the Representative unless
in the judgment of the Company and its counsel, and after notification to the Representative, such press release or communication is required
by law or applicable rules or regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">(xii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company will apply the net proceeds from the offering of the Shares in the manner set forth under &ldquo;Use of Proceeds&rdquo; in the
Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0; text-align: justify; text-indent: 85.5pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company agrees to promptly pay, or promptly reimburse if paid by the Representative, whether or not the transactions contemplated hereby
are consummated or this Agreement is terminated, all costs and expenses incident to the public offering of the Shares and the performance
of the obligations of the Company under this Agreement including those relating to: (i) the preparation, printing, reproduction, filing
and distribution of the Registration Statement including all exhibits thereto, each Preliminary Prospectus, the Prospectus, any Issuer
Free Writing Prospectus, all amendments and supplements thereto and any document incorporated by reference therein, and the printing,
filing and distribution of this Agreement; (ii) the registration or qualification of the Shares for offer and sale under the securities
or Blue Sky laws of the various jurisdictions referred to in Section 4(a)(vii), including the reasonable fees and disbursements of counsel
for the Underwriters in connection with such registration and qualification and the preparation, printing, distribution and shipment of
preliminary and supplementary Blue Sky memoranda; (iii) the furnishing (including costs of shipping and mailing) to the Representative
and to the Underwriters of copies of each Preliminary Prospectus, the Prospectus and all amendments or supplements to the Prospectus,
any Issuer Free Writing Prospectus, and of the several documents required by this Section to be so furnished, as may be reasonably requested
for use in connection with the offering and sale of the Shares by the Underwriters or by dealers to whom Shares may be sold; (iv) inclusion
of the Shares for listing on the Nasdaq Global Market; (v) all transfer taxes, if any, with respect to the sale and delivery of the Shares
by the Company to the Underwriters; (vi) the reasonable filing fees and reasonable fees and disbursements of underwriters&rsquo; counsel
incident to any required review and approval by FINRA of the terms of the sale of the Shares; (vii) all fees and disbursements of counsel
for the Underwriters in connection with the purchase and sale of the Shares and the transactions contemplated hereby; and (viii) all reasonable
and documented out of pocket expenses incurred by the Representative in connection with this Agreement and the transactions contemplated
hereby; provided that in no event shall the Company be obligated to reimburse the Underwriters under this Section 4(b) for more than $75,000
in the aggregate, including the fees and disbursements of its counsel (whether described under clauses (ii), (vi), (vii) or (viii) or
otherwise, excluding for avoidance of doubt the matters contemplated by Sections 5 and 6 of this Agreement (the &ldquo;<U>Cap</U>&rdquo;)).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0; text-align: justify; text-indent: 85.5pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="color: windowtext">The
Company acknowledges and agrees that each of the Underwriters has acted and is acting solely in the capacity of a principal in an arm&rsquo;s
length transaction between the Company, on the one hand, and the Underwriters, on the other hand, with respect to the offering of Shares
contemplated hereby (including in connection with determining the terms of the offering) and not as a financial advisor, agent or fiduciary
to the Company or any other person. Additionally, the Company acknowledges and agrees that the Underwriters have not and will not advise
the Company or any other person as to any legal, tax, investment, accounting or regulatory matters in any jurisdiction. The Company has
consulted with its own advisors concerning such matters and shall be responsible for making its own independent investigation and appraisal
of the transactions contemplated hereby, and the Underwriters shall have no responsibility or liability to the Company or any other person
with respect thereto, whether arising prior to or after the date hereof. Any review by the Underwriters of the Company, the transactions
contemplated hereby or other matters relating to such transactions have been and will be performed solely for the benefit of the Underwriters
and shall not be on behalf of the Company. The Company agrees that it will not claim that the Underwriters, or any of them, has rendered
advisory services of any nature or respect, or owes a fiduciary duty to the Company or any other person in connection with any such transaction
or the process leading thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0; text-align: justify; text-indent: 85.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0; text-align: justify; text-indent: 85.5pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
requested by the Representative, the Company will prepare a final term sheet relating to the Shares, containing only information that
describes the final terms of the Shares and otherwise in a form consented to by the Representative, and will file such final term sheet
within the period required by Rule 433(d)(5)(ii) following the date such final terms have been established. Any such final term sheet
shall be an Issuer Free Writing Prospectus for purposes of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0; text-align: justify; text-indent: 85.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0; text-align: justify; text-indent: 85.5pt">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company represents and agrees that, unless it obtains the prior written consent of the Representative, and each Underwriter represents
and agrees that, unless it obtains the prior written consent of the Company and the Representative, it has not made and will not make
any offer relating to the Shares that would constitute an &ldquo;issuer free writing prospectus,&rdquo; as defined in Rule&nbsp;433, or
that would otherwise constitute a &ldquo;free writing prospectus,&rdquo; as defined in Rule&nbsp;405, required to be filed with the Commission.
The Company has complied and will comply with the requirements of Rule 433 under the Act applicable to any Issuer Free Writing Prospectus,
including timely filing with the Commission where required, legending and record keeping. The Company represents that is has satisfied
and agrees that it will satisfy the conditions set forth in Rule 433 of the Rules to avoid a requirement to file with the Commission any
Road Show. The Company consents to the use by any Underwriter of a free writing prospectus that (a)&nbsp;is not an &ldquo;issuer free
writing prospectus&rdquo; as defined in Rule&nbsp;433 and (b)&nbsp;contains only information describing the preliminary terms of the Shares
or their offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Indemnification</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0; text-align: justify; text-indent: 85.5pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company agrees to indemnify and hold harmless each Underwriter, its officers and employees and each person, if any, who controls any Underwriter
within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act against any and all losses, claims, damages and
liabilities (including any reasonable investigation, legal and other expenses incurred in connection with, and any amount paid in settlement
of, any action, suit or proceeding or any claim asserted), joint or several, to which they, or any of them, may become subject under the
Securities Act, the Exchange Act or other Federal or state law or regulation, at common law or otherwise, insofar as such losses, claims,
damages or liabilities arise out of or are based upon (i) any untrue statement or alleged untrue statement of a material fact contained
in the Registration Statement or any amendment thereto or arise out of or are based upon any omission or alleged omission to state therein
a material fact required to be stated therein or necessary to make the statements therein not misleading, or any untrue statement or alleged
untrue statement of a material fact contained in the Preliminary Prospectus, the Statutory Prospectus, the General Disclosure Package,
the Prospectus, any Issuer Free Writing Prospectus or any &ldquo;issuer information&rdquo; filed or required to be filed pursuant to Rule
433(d) of the Rules, any amendment thereof or supplement thereto (or in any Blue Sky application or other information or other documents
executed by the Company filed in any state or other jurisdiction to qualify any or all of the Shares under the securities laws thereof
(any such application, document or information being hereinafter referred to as a &ldquo;<U>Blue Sky Application</U>&rdquo;)) or arise
out of or are based upon any omission or alleged omission to state therein a material fact required to be stated therein or necessary
to make the statements therein, in the light of the circumstances under which they were made, not misleading, (ii) in whole or in part,
any inaccuracy or breach of any representations or warranties of the Company contemplated in this Agreement or (iii) in whole or in part,
any failure of the Company to perform its obligations hereunder or under applicable law; provided, however, that such indemnity shall
not inure to the benefit of any Underwriter (or any person controlling such Underwriter) on account of any losses, claims, damages or
liabilities arising from the sale of the Shares to any person by such Underwriter if such untrue statement or omission or alleged untrue
statement or omission was made in such Preliminary Prospectus, the Registration Statement, the Prospectus, the Statutory Prospectus, the
General Disclosure Package, any Issuer Free Writing Prospectus or such amendment or supplement thereto, or in any Blue Sky Application
in reliance upon and in conformity with the Underwriter Information. This indemnity agreement will be in addition to any liability which
the Company may otherwise have.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0; text-align: justify; text-indent: 85.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0; text-align: justify; text-indent: 85.5pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Underwriter, severally and not jointly, agrees to indemnify and hold harmless the Company and each person, if any, who controls the Company
within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, each director of the Company, and each officer
of the Company who signs the Registration Statement, against any losses, claims, damages or liabilities to which such party may become
subject, under the Securities Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof)
arise out of or are based upon an untrue statement or alleged untrue statement of a material fact contained in the Registration Statement
or any amendment or supplement thereto or arise out of or are based upon the omission or alleged omission to state therein a material
fact required to be stated therein or necessary to make the statements therein not misleading, or an untrue statement or alleged untrue
statement of a material fact contained in the Preliminary Prospectus, the Prospectus, or any amendment or supplement thereto, or arise
out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary
to make the statements therein, in the light of the circumstances under which they were made, not misleading, in each case to the extent,
but only to the extent, that such untrue statement or alleged untrue statement or omission or alleged omission was made in the Preliminary
Prospectus, the Registration Statement or the Prospectus or any such amendment or supplement in reliance upon and in conformity with the
Underwriter Information; provided, however, that the obligation of each Underwriter to indemnify the Company (including any controlling
person, director or officer thereof) shall be limited to the amount of the underwriting discount and commissions applicable to the Shares
purchased by such Underwriter hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0; text-align: justify; text-indent: 85.5pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
party that proposes to assert the right to be indemnified under this Section will, promptly after receipt of notice of commencement of
any action, suit or proceeding against such party in respect of which a claim is to be made against an indemnifying party or parties under
this Section, notify each such indemnifying party of the commencement of such action, suit or proceeding, enclosing a copy of all papers
served; <U>provided</U>, <U>however</U>, that the failure to notify the indemnifying party shall not relieve such indemnifying party from
any liability it may have under this Section 5, except solely to the extent it has been materially and adversely prejudiced by such failure;
<U>provided further</U>, <U>however</U>, that the omission so to notify such indemnifying party of any such action, suit or proceeding
shall not relieve it from any liability that it may have to any indemnified party for contribution or otherwise than under this Section.
In case any such action, suit or proceeding shall be brought against any indemnified party and it shall notify the indemnifying party
of the commencement thereof, the indemnifying party shall be entitled to participate in, and, to the extent that it shall wish, jointly
with any other indemnifying party similarly notified, to assume the defense thereof, with counsel reasonably satisfactory to such indemnified
party, and after notice from the indemnifying party to such indemnified party of its election so to assume the defense thereof and the
approval by the indemnified party of such counsel, the indemnifying party shall not be liable to such indemnified party for any legal
or other expenses, except as provided below and except for the reasonable costs of investigation incurred by such indemnified party in
connection with the defense thereof. The indemnified party shall have the right to employ its counsel in any such action, but, except
as provided above, the fees and expenses of such counsel shall be at the expense of such indemnified party unless (i) the employment of
counsel by such indemnified party has been authorized in writing by the indemnifying party, (ii) the indemnified party has reasonably
concluded (based on the advice of counsel) that there may be one or more legal defenses available to it which are different from or in
addition to those available to the indemnifying party (in which case the indemnifying party shall not have the right to direct the defense
of such action on behalf of the indemnified party) or (iii) the indemnifying party shall not have employed counsel reasonably satisfactory
to the indemnified party to diligently assume the defense of such action within a reasonable time after notice of the commencement thereof,
in each of which cases the reasonable fees and expenses of one such separate counsel (and one local counsel in each relevant jurisdiction)
for such indemnified party shall be at the expense of the indemnifying party. An indemnifying party shall not be liable for any settlement
of any action, suit, and proceeding or claim effected without its written consent, which consent shall not be unreasonably withheld or
delayed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0; text-align: justify; text-indent: 0.5in">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Contribution</U>.
In order to provide for just and equitable contribution in circumstances in which the indemnification provided for in Section 5(a) or
5(b) is due in accordance with its terms but for any reason is unavailable to or insufficient to hold harmless an indemnified party in
respect to any losses, liabilities, claims, damages or expenses referred to herein, then each indemnifying party shall contribute to the
aggregate losses, liabilities, claims, damages and expenses (including any investigation, legal and other expenses reasonably incurred
in connection with, and any amount paid in settlement of, any action, suit or proceeding or any claims asserted, but after deducting any
contribution received by any person entitled hereunder to contribution from any person who may be liable for contribution) incurred by
such indemnified party, as incurred, in such proportion as is appropriate to reflect the relative benefits received by the Company on
the one hand and the Underwriters on the other hand from the offering of the Shares pursuant to this Agreement or, if such allocation
is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to above but
also the relative fault of the Company on the one hand and the Underwriters on the other hand in connection with the statements or omissions
which resulted in such losses, liabilities, claims, damages or expenses, as well as any other relevant equitable considerations. The Company
and the Underwriters agree that it would not be just and equitable if contribution pursuant to this Section 6 were determined by pro rata
allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation which does not
take account of the equitable considerations referred to above. The aggregate amount of losses, liabilities, claims, damages and expenses
incurred by an indemnified party and referred to above shall be deemed to include any legal or other expenses reasonably incurred by such
indemnified party in investigating, preparing or defending against any litigation, or any investigation or proceeding by any governmental
agency or body, commenced or threatened, or any claim whatsoever based upon any such untrue or alleged untrue statement or omission or
alleged omission. Notwithstanding the provisions of this Section 6, no Underwriter (except as may be provided in an Agreement Among Underwriters)
shall be required to contribute any amount in excess of the underwriting discount and commissions applicable to the Shares purchased by
such Underwriter. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be
entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. For purposes of this Section 6, each
person, if any, who controls an Underwriter within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act shall
have the same rights to contribution as such Underwriter, and each director of the Company including any person who, with his or her consent,
is named in the Registration Statement as about to become a director of the Company, each officer of the Company who signed the Registration
Statement, and each person, if any, who controls the Company within the meaning of the Section 15 of the Securities Act or Section 20
of the Exchange Act, shall have the same rights to contribution as the Company. Any party entitled to contribution will, promptly after
receipt of notice of commencement of any action, suit or proceeding against such party in respect of which a claim for contribution may
be made against another party or parties under this Section 6, notify such party or parties from whom contribution may be sought, but
the omission so to notify such party or parties from whom contribution may be sought shall not relieve the party or parties from whom
contribution may be sought from any other obligation it or they may have hereunder or otherwise than under this Section 6. No party shall
be liable for contribution with respect to any action, suit, proceeding or claim settled without its written consent. The Underwriter&rsquo;s
obligations to contribute pursuant to this Section 6 are several in proportion to their respective underwriting commitments and not joint.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0; text-align: justify; text-indent: 85.5pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition to Section 3 hereof, this Agreement may be terminated with respect to the Shares to be purchased on a Closing Date by the Representative
by notifying the Company at any time at or before such Closing Date in the absolute discretion of the Representative if: (i) in the judgment
of the Representative, there has occurred any material adverse change in the securities markets or any event, act or occurrence that has
materially disrupted, or in the judgment of the Representative, will in the future materially disrupt, the securities markets or there
shall be such a material adverse change in general financial, political or economic conditions or the effect of international conditions
on the financial markets in the United States is such as to make it, in the judgment of the Representative, inadvisable or impracticable
to market the Shares or enforce contracts for the sale of the Shares; (ii) there has occurred any outbreak or material escalation of hostilities
or acts of terrorism or other calamity or crisis the effect of which on the financial markets of the United States is such as to make
it, in the judgment of the Representative, inadvisable or impracticable to market the Shares or enforce contracts for the sale of the
Shares; (iii) trading in the Shares or any securities of the Company has been suspended or materially limited by the Commission or the
Nasdaq Global Market or trading generally on the Nasdaq Global Market or the New York Stock Exchange has been suspended or materially
limited, or minimum or maximum ranges for prices for securities shall have been fixed, or maximum ranges for prices for securities have
been required, by any of said exchanges or by such system or by order of the Commission, FINRA, or any other governmental or regulatory
authority; (iv) a banking moratorium has been declared by any state or Federal authority; or (v) in the reasonable judgment of the Representative,
there has been, since the time of execution of this Agreement, any material adverse change in the assets, liabilities, properties, condition
(financial or otherwise), or in the results of operations, business or business prospects of the Company and its subsidiaries considered
as a whole, whether or not arising in the ordinary course of business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0; text-align: justify; text-indent: 85.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0; text-align: justify; text-indent: 85.5pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
this Agreement is terminated pursuant to any of its provisions, the Company shall not be under any liability to any Underwriter (other
than in the event of an intentional or willful breach of this Agreement by the Company), and no Underwriter shall be under any liability
to the Company, except that (y) if this Agreement is terminated by the Representative or the Underwriters because of any failure, refusal
or inability on the part of the Company to comply with the terms or to fulfill any of the conditions of this Agreement (including Section
3 or 4 hereof) or pursuant to Section 7(a), subject to the Cap, the Company shall promptly reimburse the Underwriters for their reasonable
out-of-pocket expenses (including the reasonable fees and disbursements of their counsel) incurred by the Underwriters in connection with
the proposed purchase and sale of the Shares or in contemplation of performing their obligations hereunder and (z) no Underwriter who
shall have failed or refused to purchase the Shares agreed to be purchased by it under this Agreement, without some reason sufficient
hereunder to justify cancellation or termination of its obligations under this Agreement, shall be relieved of liability to the Company
or to the other Underwriters for damages occasioned by its failure or refusal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Substitution
of Underwriters</U>. If any Underwriter shall default in its obligation to purchase on any Closing Date the Shares agreed to be purchased
hereunder on such Closing Date, the Representative shall have the right, within 36 hours thereafter, to make arrangements for one or more
of the non-defaulting Underwriters, or any other underwriters, to purchase such Shares on the terms contained herein. If, however, the
Representative shall not have completed such arrangements within such 36-hour period, then the Company shall be entitled to a further
period of thirty-six hours within which to procure another party or other parties satisfactory to the Underwriters to purchase such Shares
on such terms. If, after giving effect to any arrangements for the purchase of the Shares of a defaulting Underwriter or Underwriters
by the Representative and the Company as provided above, the aggregate number of Shares which remains unpurchased on such Closing Date
does not exceed 10% of the aggregate number of all the Shares that all the Underwriters are obligated to purchase on such date, then the
Company shall have the right to require each non-defaulting Underwriter to purchase the number of Shares which such Underwriter agreed
to purchase hereunder at such date and, in addition, to require each non-defaulting Underwriter to purchase its pro rata share (based
on the number of Shares which such Underwriter agreed to purchase hereunder) of the Shares of such defaulting Underwriter or Underwriters
for which such arrangements have not been made; but nothing herein shall relieve a defaulting Underwriter from liability for its default.
In any such case, either the Representative or the Company shall have the right to postpone the applicable Closing Date for a period of
not more than seven days in order to effect any necessary changes and arrangements (including any necessary amendments or supplements
to the Registration Statement or Prospectus or any other documents), and the Company agrees to file promptly any amendments to the Registration
Statement or the Prospectus which in the opinion of the Company and the Underwriters and their counsel may thereby be made necessary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">If, after giving effect to any
arrangements for the purchase of the Shares of a defaulting Underwriter or Underwriters by the Representative and the Company as provided
above, the aggregate number of such Shares which remains unpurchased exceeds 10% of the aggregate number of all the Shares to be purchased
at such date, then this Agreement, or, with respect to a Closing Date which occurs after the Firm Shares Closing Date, the obligations
of the Underwriters to purchase and of the Company to sell the Option Shares to be purchased and sold on such date, shall terminate, without
liability on the part of any non-defaulting Underwriter to the Company, and without liability on the part of the Company, except as provided
in Sections 4(b), 5, 6 and 7. The provisions of this Section 8 shall not in any way affect the liability of any defaulting Underwriter
to the Company or the non-defaulting Underwriters arising out of such default. The term &ldquo;Underwriter&rdquo; as used in this Agreement
shall include any person substituted under this Section 8 with like effect as if such person had originally been a party to this Agreement
with respect to such Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0; text-align: justify; text-indent: 0.5in">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Miscellaneous</U>.
The respective agreements, representations, warranties, indemnities and other statements of the Company and the several Underwriters,
as set forth in this Agreement or made by or on behalf of them pursuant to this Agreement, shall remain in full force and effect, regardless
of any investigation (or any statement as to the results thereof) made by or on behalf of any Underwriter or the Company or any of their
respective officers, directors or controlling persons referred to in Sections 5 and 6 hereof, and shall survive delivery of and payment
for the Shares. In addition, the provisions of Sections 4(b), 5, 6, 7 and 9 shall survive the termination or cancellation of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">This Agreement has been and
is made for the benefit of the Underwriters, the Company and their respective successors and assigns, and, to the extent expressed herein,
for the benefit of persons controlling any of the Underwriters, or the Company, and directors and officers of the Company, and their respective
successors and assigns, and no other person shall acquire or have any right under or by virtue of this Agreement. The term &ldquo;successors
and assigns&rdquo; shall not include any purchaser of Shares from any Underwriter merely because of such purchase.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">All notices and communications
hereunder shall be in writing and mailed or delivered or by telephone or facsimile if subsequently confirmed in writing, (a) if to the
Representative, c/o Roth Capital Partners, LLC, 888 San Clemente Drive, Newport Beach, CA 92660, telecopy number: (949) 720-7227, Attention:&nbsp;Equity
Capital Markets with a copy to Pillsbury Winthrop Shaw Pittman LLP, 31 W. 52<SUP>nd</SUP> Street, New York, NY 10019, Attention: Jonathan
J. Russo, Esq., Facsimile: (212) 858-1500 and (b) if to the Company, at its address as it appears on the cover page of the Registration
Statement, Attention: Bart C. Shuldman with a copy to Day Pitney LLP, 605 Third Avenue, 31st Floor, New York, NY 10158, Attention: Scott
Warren Goodman, Esq., Facsimile: (212) 916-2940.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The Company (on its behalf and,
to the extent permitted by applicable law, on behalf of its stockholders and affiliates) and each Underwriter each hereby irrevocably
waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or
relating to this Agreement or the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>This Agreement shall be governed
by and construed in accordance with the laws of the State of New York.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Any legal suit, action or proceeding
arising out of or based upon this Agreement or the transactions contemplated hereby shall be instituted in (i) the federal courts of the
United States of America located in the City and County of New York, Borough of Manhattan or (ii) the courts of the State of New York
located in the City and County of New York, Borough of Manhattan (collectively, the &ldquo;<U>Specified Courts</U>&rdquo;), and each party
irrevocably submits to the exclusive jurisdiction (except for proceedings instituted in regard to the enforcement of a judgment of any
such court, as to which such jurisdiction is non-exclusive) of such courts in any such suit, action or proceeding. Service of any process,
summons, notice or document by mail to such party&rsquo;s address set forth above shall be effective service of process for any suit,
action or other proceeding brought in any such court. The parties irrevocably and unconditionally waive any objection to the laying of
venue of any suit, action or other proceeding in the Specified Courts and irrevocably and unconditionally waive and agree not to plead
or claim in any such court that any such suit, action or other proceeding brought in any such court has been brought in an inconvenient
forum.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">TIME SHALL BE OF THE ESSENCE
OF THIS AGREEMENT. EXCEPT AS OTHERWISE SET FORTH HEREIN, SPECIFIED TIMES OF DAY REFER TO NEW YORK CITY TIME.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">This Agreement may be executed
in any number of counterparts, each of which shall be deemed to be an original, but all such counterparts shall together constitute one
and the same agreement. The words &ldquo;execution,&rdquo; signed&rdquo; and &ldquo;signature&rdquo; and words of like import in this
Agreement and all documents relating thereto, shall include images of manually executed signatures transmitted by facsimile or other electronic
format (including, without limitation, &ldquo;pdf,&rdquo; &ldquo;tif&rdquo; or &ldquo;jpg&rdquo;) and other electronic signatures (including,
without limitation, DocuSign and AdobeSign). The use of electronic signatures and electronic records (including, without limitation, any
contract or other record created, generated, sent, communicated, received or stored by electronic means) shall be of the same legal effect,
validity and enforceability as a manually executed signature or use of a paper based record-keeping system to the fullest extent permitted
by applicable law, including, without limitation, the Electronic Signatures in Global and National Commerce Act, the New York State Electronic
Signatures and Records Act and any other applicable law, including, without limitation, any state law based on the Uniform Electronic
Transactions Act or the Uniform Commercial Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The Section headings herein
are for convenience only and shall not affect the construction hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">This Agreement may be signed
in any number of counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon
the same instrument.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Please confirm that the foregoing
correctly sets forth the agreement among us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <TR STYLE="vertical-align: top">
        <TD>&nbsp;</TD>
        <TD COLSPAN="2">Very truly yours,</TD></TR>
    <TR STYLE="vertical-align: top">
        <TD>&nbsp;</TD>
        <TD COLSPAN="2">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top">
        <TD>&nbsp;</TD>
        <TD COLSPAN="2">TRANSACT TECHNOLOGIES INCORPORATED</TD></TR>
    <TR STYLE="vertical-align: top">
        <TD STYLE="width: 50%">&nbsp;</TD>
        <TD STYLE="width: 3%">&nbsp;</TD>
        <TD STYLE="width: 47%">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top">
        <TD>&nbsp;</TD>
        <TD>&nbsp;</TD>
        <TD>&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top">
        <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
        <TD STYLE="padding-bottom: 1pt">By:</TD>
        <TD STYLE="border-bottom: Black 1pt solid">/s/ Bart C. Shuldman </TD></TR>
    <TR STYLE="vertical-align: top">
        <TD>&nbsp;</TD>
        <TD>&nbsp;</TD>
        <TD>Name: Bart C. Shuldman</TD></TR>
    <TR STYLE="vertical-align: top">
        <TD>&nbsp;</TD>
        <TD>&nbsp;</TD>
        <TD>Title: Chief Executive Officer</TD></TR>
    </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Confirmed:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
    <TR STYLE="vertical-align: top">
        <TD COLSPAN="4">ROTH CAPITAL PARTNERS, LLC</TD></TR>
    <TR STYLE="vertical-align: top">
        <TD>&nbsp;</TD>
        <TD COLSPAN="3">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top">
        <TD>&nbsp;</TD>
        <TD COLSPAN="3">Acting severally on behalf of itself</TD></TR>
    <TR STYLE="vertical-align: top">
        <TD>&nbsp;</TD>
        <TD COLSPAN="3">and as representative of the several</TD></TR>
    <TR STYLE="vertical-align: top">
        <TD>&nbsp;</TD>
        <TD COLSPAN="3">Underwriters named in Schedule I annexed hereto.</TD></TR>
    <TR STYLE="vertical-align: top">
        <TD>&nbsp;</TD>
        <TD COLSPAN="3">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top">
        <TD>By:&nbsp;&nbsp;</TD>
        <TD COLSPAN="3">ROTH CAPITAL PARTNERS, LLC</TD></TR>
    <TR STYLE="vertical-align: top">
        <TD>&nbsp;</TD>
        <TD COLSPAN="3">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top">
        <TD>&nbsp;</TD>
        <TD COLSPAN="3">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top">
        <TD STYLE="padding-bottom: 1pt; width: 8%">&nbsp;</TD>
        <TD STYLE="padding-bottom: 1pt; width: 4%">By:</TD>
        <TD STYLE="border-bottom: Black 1pt solid; width: 35%">/s/ Aaron M. Gurewitz</TD>
        <TD STYLE="padding-bottom: 1pt; width: 53%">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top">
        <TD>&nbsp;</TD>
        <TD>&nbsp;</TD>
        <TD COLSPAN="2">Name: Aaron M. Gurewitz</TD></TR>
    <TR STYLE="vertical-align: top">
        <TD>&nbsp;</TD>
        <TD>&nbsp;</TD>
        <TD COLSPAN="2">Title: Head of Equity Capital Markets</TD></TR>
    </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[Signature Page to the Underwriting Agreement]</P>

<!-- Field: Page; Sequence: 31; Options: NewSection -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SCHEDULE I</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
    <TR STYLE="vertical-align: top">
        <TD STYLE="width: 52%">&nbsp;</TD>
        <TD STYLE="width: 7%">&nbsp;</TD>
        <TD STYLE="width: 41%">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: bottom">
        <TD><U>Name</U></TD>
        <TD>&nbsp;</TD>
        <TD STYLE="text-align: center"><U>Number of Firm Shares to&nbsp;Be Purchased from the Company</U></TD></TR>
    <TR>
        <TD STYLE="vertical-align: top">&nbsp;</TD>
        <TD STYLE="vertical-align: top">&nbsp;</TD>
        <TD STYLE="text-align: right">&nbsp;</TD></TR>
    <TR STYLE="background-color: rgb(204,238,255)">
        <TD STYLE="vertical-align: top">Roth Capital Partners, LLC</TD>
        <TD STYLE="vertical-align: top">&nbsp;</TD>
        <TD STYLE="text-align: right">504,509</TD></TR>
    <TR STYLE="background-color: White">
        <TD STYLE="vertical-align: top">Craig-Hallum Capital Group LLC</TD>
        <TD STYLE="vertical-align: top">&nbsp;</TD>
        <TD STYLE="text-align: right">191,366</TD></TR>
    <TR STYLE="background-color: rgb(204,238,255)">
        <TD STYLE="vertical-align: top">Barrington Research Associates, Inc.</TD>
        <TD STYLE="vertical-align: top">&nbsp;</TD>
        <TD STYLE="text-align: right">36,625</TD></TR>
    <TR STYLE="vertical-align: top; background-color: White">
        <TD STYLE="border-top: Black 1pt solid; text-align: right">&nbsp;</TD>
        <TD>&nbsp;</TD>
        <TD STYLE="border-top: Black 1pt solid; text-align: right">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
        <TD STYLE="text-align: right">Total</TD>
        <TD>&nbsp;</TD>
        <TD STYLE="text-align: right">732,500</TD></TR>
    </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 32; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: UpperRoman; Name: PageNo -->I<!-- Field: /Sequence -->-1</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SCHEDULE II</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Issuer Free Writing Prospectuses included in the General Disclosure
Package</U></B>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">None</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: UpperRoman; Name: PageNo -->II<!-- Field: /Sequence -->-1</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SCHEDULE III</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Statutory Prospectus:</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD>Preliminary Prospectus filed on August 11, 2021</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2.</TD><TD>The following orally communicated pricing information:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Firm Shares offered by the Company: 732,500</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Option Shares offered by the Company: 109,875</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Price to Public: $14.50 per share</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Underwriting discounts and commissions: $0.87 per share</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: UpperRoman; Name: PageNo -->III<!-- Field: /Sequence -->-1</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SCHEDULE IV</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Lock-up Signatories</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Donald E. Brooks</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Tracey S. Chernay</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Steven A. DeMartino</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">John M. Dillon</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Randall S. Friedman</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Emanuel P.N. Hilario</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Andrew J. Hoffman</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Haydee O. Olinger</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">David B. Peters</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Brent Richtsmeier</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Bart C. Shuldman<BR>
Raymond T. Walsh, Jr.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: UpperRoman; Name: PageNo -->IV<!-- Field: /Sequence -->-1</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">DISCLOSURE SCHEDULE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section 2(s):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: justify">Any prepayment of outstanding borrowings under the Loan and Security Agreement, dated as of March 13,
2020, among Siena Lending Group, LLC, as lender, the Company, as borrower, and the other loan parties from time to time party thereto
that may be required pursuant to Section 1.8(a) thereof. As of August 11, 2021, no borrowings were outstanding under such agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 36; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">Disc. Sch.-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">EXHIBIT A</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Form of Lock-Up Agreement</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">__________, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Roth Capital Partners, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">888 San Clemente Drive</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Newport Beach, CA 92660</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As Representative of the several<BR>
Underwriters to be named in the</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">within-mentioned Underwriting Agreement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Re:&#9;<U>TransAct Technologies Incorporated &ndash;
Registered Public Offering of Common Stock</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order to induce Roth Capital
Partners, LLC (the &ldquo;<B>Representative</B>&rdquo;) to enter into a certain underwriting agreement (the &ldquo;<B>Underwriting Agreement</B>&rdquo;)
with TransAct Technologies Incorporated, a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), with respect to a registered public
offering of shares (the &ldquo;<B>Offering</B>&rdquo;) of the Company&rsquo;s Common Stock, $.01 par value per share (&ldquo;<B>Common
Stock</B>&rdquo;), the undersigned hereby agrees that for a period (the &ldquo;<B>Lock-Up Period</B>&rdquo;) commencing on the date hereof
and continuing through the close of trading on the date ninety (90) days following the date of the final prospectus filed by the Company
with the Securities and Exchange Commission in connection with the Offering, the undersigned will not, without the prior written consent
of the Representative, directly or indirectly, (i) sell, assign, transfer, pledge, offer to sell, contract to sell, sell any option or
contract to purchase, purchase any option or contract to sell, grant any option for sale (including any short sale), right or warrant
to purchase, lend, establish an open &ldquo;put equivalent position&rdquo; (within the meaning of Rule 16a-1(h) under the Securities Exchange
Act of 1934, as amended (the &ldquo;<B>Exchange Act</B>&rdquo;)), or otherwise dispose of, or enter into any transaction which is designed
to or could be expected to result in the disposition of, any shares of Common Stock or securities convertible into or exercisable or exchangeable
for any equity securities of the Company (including, without limitation, shares of Common Stock or any such securities which may be deemed
to be beneficially owned by the undersigned in accordance with the rules and regulations promulgated by the Securities and Exchange Commission
from time to time (such shares or securities, the &ldquo;<B>Beneficially Owned Shares</B>&rdquo;)), or publicly announce any intention
to do any of the foregoing, other than the exercise of options or warrants so long as there is no sale or disposition of the Common Stock
underlying such options or warrants during the Lock-Up Period, (ii) enter into any swap, hedge or other agreement or arrangement that
transfers in whole or in part, the economic risk of ownership of any Beneficially Owned Shares, Common Stock or securities convertible
into or exercisable or exchangeable for any equity securities of the Company, or (iii) engage in any short selling of any Beneficially
Owned Shares, Common Stock or securities convertible into or exercisable or exchangeable for any equity securities of the Company, whether
any such transaction described in clause (i), (ii) or (iii) above is to be settled by delivery of shares of Common Stock or such other
securities, in cash or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 37; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, notwithstanding
the foregoing, the restrictions set forth herein shall not apply to the establishment of a trading plan that complies with Rule 10b5-1
under the Exchange Act; <I>provided however</I>, that the restrictions shall apply in full force to sales pursuant to the trading plan
during the Lock-Up Period. Furthermore, notwithstanding anything herein to the contrary, the restrictions will not apply to the sale of
shares of Common Stock pursuant to a trading plan that complies with Rule 10b5-1 and existing on the date of this Lock-Up Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Anything contained herein
to the contrary notwithstanding, any person to whom shares of Common Stock, securities convertible into or exercisable or exchangeable
for any equity securities of the Company or Beneficially Owned Shares are transferred from the undersigned shall be bound by the terms
of this Lock-Up Agreement. This Lock-Up Agreement is irrevocable and will be binding on the undersigned and the respective successors,
heirs, personal representatives, and assigns of the undersigned.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the undersigned
hereby waives, from the date hereof until the expiration of the Lock-Up Period, any and all rights, if any, to request or demand registration
pursuant to the Securities Act of 1933, as the same may be amended or supplemented from time to time, of any shares of Common Stock or
securities convertible into or exercisable or exchangeable for any equity securities of the Company that are registered in the name of
the undersigned or that are Beneficially Owned Shares. In order to enable the aforesaid covenants to be enforced, the undersigned hereby
consents to the placing of legends and/or stop transfer orders with the transfer agent of the Common Stock with respect to any shares
of Common Stock, securities convertible into or exercisable or exchangeable for any equity securities of the Company or Beneficially
Owned Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding the foregoing,
and subject to the conditions below, the undersigned may transfer the Beneficially Owned Shares in the transactions listed as clauses
(i) - (vi) below, without the prior written consent of the Representative, provided that (1) prior to each such transfer, the Representative
shall have received a duplicate form of this Lock-Up Agreement executed and delivered by each donee, trustee, distributee or transferee,
as the case may be, (2) no such transfer shall involve a disposition for value, (3) each such transfer (other than transfers under clauses
(ii) and (v) below) shall not be required to be reported as a reduction in beneficial ownership in any public report, announcement or
filing made or to be made with the Securities and Exchange Commission or otherwise during the Lock-Up Period and (4) the undersigned does
not otherwise voluntarily effect any public filing, announcement or report regarding any such transfer during the Lock-Up Period:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 27pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)</FONT></TD><TD STYLE="text-align: justify">as a bona fide gift or gifts;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 27pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">(ii)</FONT></TD><TD STYLE="text-align: justify">by operation of law, including pursuant to a qualified domestic order or in connection with a divorce
settlement;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 27pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iii)</FONT></TD><TD STYLE="text-align: justify">to the immediate family of the undersigned;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 27pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iv)</FONT></TD><TD STYLE="text-align: justify">to any trust for the direct or indirect benefit of the undersigned or the immediate family of the undersigned;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 27pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">(v)</FONT></TD><TD STYLE="text-align: justify">to any beneficiary of the undersigned pursuant to a will or other testamentary document or applicable
laws of descent; or</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 27pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">(vi)</FONT></TD><TD STYLE="text-align: justify">to any corporation, partnership, limited liability company or other entity all of the beneficial ownership
interests of which are held by the undersigned or the immediate family of the undersigned.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Lock-Up Agreement shall
not apply to: (i) the transfer of Beneficially Owned Shares pursuant to a bona fide third party tender offer, merger, consolidation or
other similar transaction made to all holders of the Common Stock involving a change of control (as hereinafter defined) of the Company,
provided that in the event that the tender offer, merger, consolidation or other such transaction is not completed, the Beneficially Owned
Securities owned by the undersigned shall remain subject to the restrictions contained herein; (ii) transactions relating to shares of
Common Stock or other securities acquired in open market transactions after the completion of the Offering, provided that no filing under
Section 16(a) of the Exchange Act shall be required or shall be voluntarily made in connection with subsequent sales of Common Stock or
other securities acquired in such open market transactions; or (iii) transfers to the Company in connection with the exercise of options
or warrants on a &ldquo;cashless&rdquo; or &ldquo;net exercise&rdquo; basis or to cover tax withholding obligations upon the exercise
of options or warrants or the vesting of restricted stock units, provided that any related filing under Section 16(a) of the Exchange
Act reporting a disposition of shares of Common Stock made in connection with such exercise shall contain a description of the transaction
and indicate that the disposition was made as part of such exercise or to cover tax withholding obligations in connection therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Lock-Up Agreement shall
automatically terminate upon the earlier of (i) August 31, 2021, in the event that no shares of Common Stock have been sold pursuant to
the Offering by such date, (ii) the termination of the Underwriting Agreement if such agreement is terminated prior to the Firm Shares
Closing Date (as such term is defined in the Underwriting Agreement) in accordance with its terms, (iii) the Representative, on the one
hand, or the Company, on the other hand, advising the other in writing, prior to the execution of the Underwriting Agreement, that they
have or it has, as the case may be, determined not to proceed with the Offering, and (iv) the consummation of a &ldquo;change of control&rdquo;
of the Company, meaning (a) the consummation of a reorganization, merger or consolidation, or sale or other disposition of all or substantially
all of the assets of the Company, or (b) the acquisition by any individual, entity or group (within the meaning of Section 13(d)(3) or
14(d)(2) of the Exchange Act) of beneficial ownership (within the meaning of Rule 13d-3 promulgated under such Act) of more than fifty
percent (50%) of either (i) the then outstanding shares of Common Stock of the Company; or (ii) the combined voting power of the then
outstanding voting securities of the Company entitled to vote generally in the election of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Lock-Up Agreement shall
be governed by, and construed in accordance with, the laws of the State of New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><I>(Remainder of page intentionally
left blank. Signature page to follow.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Lock-Up Agreement has been executed as of
the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
    <TR STYLE="vertical-align: top">
        <TD>&nbsp;</TD>
        <TD COLSPAN="2">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
    <TR STYLE="vertical-align: top">
        <TD STYLE="width: 50%">&nbsp;</TD>
        <TD STYLE="width: 3%">By:</TD>
        <TD STYLE="width: 47%; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top">
        <TD>&nbsp;</TD>
        <TD>&nbsp;</TD>
        <TD>Signature</TD></TR>
    <TR STYLE="vertical-align: top">
        <TD>&nbsp;</TD>
        <TD COLSPAN="2">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top">
        <TD>&nbsp;</TD>
        <TD COLSPAN="2">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top">
        <TD>&nbsp;</TD>
        <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
    <TR STYLE="vertical-align: top">
        <TD>&nbsp;</TD>
        <TD COLSPAN="2">Printed Name of Person Signing</TD></TR>
    </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">EXHIBIT B</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>Form of Day Pitney LLP Opinion</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">B-1</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2px solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>ex5_1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%; border-bottom: black 1pt solid; font-size: 10pt">&nbsp;<IMG SRC="daypitneylogo.jpg" ALT=""></TD>
    <TD STYLE="width: 51%; border-bottom: black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 5.1</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P></TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-transform: uppercase">Boston&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Connecticut&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;FLORIDA&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;New Jersey&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;New York&nbsp;&nbsp;&nbsp;PROVIDENCE&nbsp;&nbsp;Washington, DC</TD></TR>
  </TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 55%">&nbsp;</TD>
    <TD STYLE="width: 45%">August 16, 2021</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">TransAct Technologies Incorporated</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">One Hamden Center</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2319 Whitney Avenue, Suite 3B</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Hamden, Connecticut 06518</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have acted as counsel for
TransAct Technologies Incorporated, a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), in connection with the issuance and sale
of 732,500 shares of the Company&rsquo;s common stock, par value $.01 per share (the &ldquo;<U>Securities</U>&rdquo;), in a registered
public offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection therewith, we
have examined (i)&nbsp;the Registration Statement on Form S-3 (File No.&nbsp;333-248055) (the &ldquo;<U>Initial Registration Statement</U>&rdquo;)
filed by the Company with the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;) under the Securities Act of 1933,
as amended (the &ldquo;<U>Securities Act</U>&rdquo;) on August 17, 2020, (ii) the Registration Statement on Form S-3 (File No. 333-258738)
filed by the Company with the Commission on August 11, 2021 pursuant to Rule 462(b) promulgated under the Securities Act (together with
the Initial Registration Statement, the &ldquo;<U>Registration Statements</U>&rdquo;), (iii)&nbsp;the prospectus of the Company, dated
August 21, 2020, which forms a part of the Registration Statements, as supplemented by the prospectus supplement, dated August 12, 2021
(the &ldquo;<U>Prospectus Supplement</U>&rdquo;), relating to the offer and sale of the Securities, as filed with the Commission pursuant
to Rule 424(b) under the Securities Act (as so supplemented, the &ldquo;<U>Prospectus</U>&rdquo;) and (iv) the Underwriting Agreement,
dated August 12, 2021 (the &ldquo;<U>Underwriting Agreement</U>&rdquo;), between the Company and Roth Capital Partners, LLC, as representative
of the several underwriters listed in Schedule I thereto. In addition, we have examined originals, or copies certified or otherwise identified
to our satisfaction, of the Certificate of Incorporation of the Company, as amended, and the Amended and Restated By-laws of the Company,
each as currently in effect, relevant resolutions of the Board of Directors of the Company or committees thereof and such corporate records,
documents, agreements, instruments and certificates of public officials of the State of Delaware and of officers of the Company as we
have deemed necessary or appropriate in order to express the opinions hereinafter set forth.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0pt 0; text-indent: 36pt">In such examination, we have assumed, without inquiry, the legal capacity of all natural persons, the genuineness
of all signatures on all documents examined by us, the authenticity of all documents submitted to us as originals, the conformity to the
original documents of all such documents submitted to us as copies and the authenticity of the originals of such latter documents. We
have also assumed that the books and records of the Company are maintained in accordance with proper corporate procedures. As to any facts
material to our opinion, we have, when relevant facts were not independently established, relied upon the aforementioned records, documents,
agreements, instruments and certificates and upon statements and certificates of officers and representatives of the Company and public
officials.</P>

<P STYLE="margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;<IMG SRC="daypitney_logosmall.jpg" ALT=""></P>

<P STYLE="margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">TransAct Technologies Incorporated</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">August 16, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page 2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based upon, and subject to,
the foregoing, and subject to the limitations, qualifications and assumptions stated herein, we are of the opinion that, when the Securities
have been issued and paid for in accordance with the terms of the Underwriting Agreement and as described in the Registration Statements
and the Prospectus, the Securities will be validly issued, fully paid and nonassessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing opinion is limited
to the General Corporation Law of the State of Delaware. We express no opinion as to the effect of the laws of any other jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This opinion is being furnished
in connection with the requirements of Item 601(b)(5) of Regulation S-K under the Securities Act, and no opinion is expressed herein as
to any matter pertaining to the contents of the Registration Statements or the Prospectus, other than as expressly stated herein with
respect to the issuance of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We hereby consent to the filing
of this opinion as an exhibit to the Company&rsquo;s Current Report on Form 8-K filed with the Commission on August 16, 2021, which is
incorporated by reference in the Initial Registration Statement and the Prospectus, and to the reference to this firm under the heading
&ldquo;Legal Matters&rdquo; in the Prospectus Supplement and the Prospectus. In giving such consent, we do not hereby concede that we
are within the category of persons whose consent is required under Section 7 of the Securities Act, or the rules and regulations of the
Commission thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 47%">&nbsp;</TD>
    <TD STYLE="width: 53%">Very truly yours,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>/s/ Day Pitney LLP </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>DAY PITNEY LLP</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">SWG; ESK</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2px solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>ex99_1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><IMG SRC="transactlogo_small.jpg" ALT=""><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TransAct Technologies Announces Proposed Public
Offering of Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Hamden, CT &ndash; August 11, 2021 &ndash;
</B>TransAct Technologies Incorporated (Nasdaq: TACT) (&ldquo;TransAct,&rdquo; the &ldquo;Company,&rdquo; &ldquo;we&rdquo; or &ldquo;our&rdquo;),
a global leader in software-driven technology and printing solutions for high-growth markets, today announced that it intends to offer
newly issued shares of its common stock in an underwritten public offering. TransAct also expects to grant to the underwriters of the
offering a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the underwritten public offering
on the same terms and conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Roth Capital Partners is acting as the sole book-running
manager for the offering, and Craig-Hallum Capital Group is acting as co-manager for the offering. The offering is subject to market and
other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the size or terms of the
offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">TransAct intends to use the net proceeds from
the offering for working capital and other general corporate purposes, which may include funding the further development of TransAct&rsquo;s
food service technology business and related sales, marketing and product development efforts, technology improvements and personnel costs
in support of TransAct&rsquo;s growth strategy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A shelf registration statement relating to the
shares of common stock to be issued in the proposed offering was filed with the Securities and Exchange Commission (the &ldquo;SEC&rdquo;)
on August 17, 2020 and is effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any
of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Copies of the preliminary prospectus supplement and accompanying prospectus will be filed with the SEC and, when available, may be obtained
from Roth Capital Partners, LLC, 888 San Clemente, Suite 400, Newport Beach, CA 92660, by email at rothecm@roth.com or by telephone at
(800) 678-9147, or by accessing the SEC&rsquo;s website, www.sec.gov.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About TransAct Technologies Incorporated</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">TransAct Technologies Incorporated is a global
leader in developing software-driven technology and printing solutions for high-growth markets including food service, casino and gaming,
POS automation, and oil and gas. The Company&rsquo;s solutions are designed from the ground up based on customer requirements and are
sold under the BOHA! &trade;, AccuDate&trade;, EPICENTRAL&reg;, Epic, Ithaca&reg; and Printrex&reg; brands. TransAct has sold over 3.5
million printers, terminals and other hardware devices around the world and is committed to providing world-class service, spare parts
and accessories to support its installed product base. Through the TransAct Services Group, the Company also provides customers with a
complete range of supplies and consumable items both online at http://www.transactsupplies.com and through its direct sales team. TransAct
is headquartered in Hamden, CT. For more information, please visit http://www.transact-tech.com or call (203) 859-6800.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">TransAct&reg;, BOHA!&trade;, AccuDate&trade;,
Epic, EPICENTRAL&reg;, Ithaca&reg; and Printrex&reg; are trademarks of TransAct Technologies Incorporated. &copy;2021 TransAct Technologies
Incorporated. All rights reserved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward-Looking Statements </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain statements in this press release include
forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology, such as
&ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;expect,&rdquo; &ldquo;intend,&rdquo; &ldquo;estimate,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo;
&ldquo;project,&rdquo; &ldquo;plan&rdquo; or &ldquo;continue,&rdquo; or the negative thereof, or other similar words. All forward-looking
statements involve risks and uncertainties, including, but not limited to, the adverse effects of the COVID-19 pandemic, related vaccination
rates and the emergence of virus variants on our business, operations, financial condition, results of operations and capital resources,
including as a result of supply chain disruptions, shutdowns and/or operational restrictions imposed on our customers, an inability of
our customers to make payments on time or at all, diversion of management attention, necessary modifications to our business practices
and operations, cost cutting measures we have made and may continue to make, a possible future reduction in the value of goodwill or other
intangible assets, inadequate manufacturing capacity or a shortfall or excess of inventory as a result of difficulty in predicting manufacturing
requirements due to volatile economic conditions, price increases or decreased availability of component parts or raw materials, exchange
rate fluctuations, volatility of and decreases in trading prices of our common stock and the availability of needed financing on acceptable
terms or at all; our ability to successfully develop new products that garner customer acceptance and generate sales, both domestically
and internationally, in the face of substantial competition; our reliance on an unrelated third party to develop, maintain and host certain
web-based food service application software and develop and maintain selected components of our downloadable software applications pursuant
to a non-exclusive license agreement, and the risk that interruptions in our relationship with that third party could materially impair
our ability to provide services to our food service technology customers on a timely basis or at all and could require substantial expenditures
to find or develop alternative software products; our ability to successfully transition our business into the food service technology
market; our ability to fully remediate a previously disclosed material weakness in our internal control over financial reporting; risks
associated with potential future acquisitions; general economic conditions; our dependence on contract manufacturers for the assembly
of a large portion of our products in Asia; our dependence on significant suppliers; our ability to recruit and retain quality employees
as the Company grows; our dependence on third parties for sales outside the United States; our dependence on technology licenses from
third parties; marketplace acceptance of new products; risks associated with foreign operations; the availability of third-party components
at reasonable prices; price wars or other significant pricing pressures affecting the Company&rsquo;s products in the United States or
abroad; increased product costs or reduced customer demand for our products due to changes in U.S. policy that may result in trade wars
or tariffs; our ability to protect intellectual property; the effect of the United Kingdom&rsquo;s withdrawal from the European Union;
and other risk factors detailed in the Company&rsquo;s Annual Report on Form 10-K for the year ended December 31, 2020, and other reports
filed with the SEC. Actual results may differ materially from those discussed in, or implied by, the forward-looking statements. The forward-looking
statements speak only as of the date of this release, and the Company assumes no duty to update them to reflect new, changing or unanticipated
events or circumstances, except as required by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"># # #</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor Contact: </B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 34%">Bart Shuldman</TD>
    <TD STYLE="width: 36%">Michael Bowen</TD>
    <TD STYLE="width: 30%">Ryan Gardella</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>Chairman and Chief Executive Officer</TD>
    <TD>ICR, Inc.</TD>
    <TD>ICR, Inc.</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>TransAct Technologies Incorporated</TD>
    <TD>Michael.Bowen@icrinc.com&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD>Ryan.Gardella@icrinc.com</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>702-388-8180</TD>
    <TD>203-682-8299</TD>
    <TD>203-682-8240</TD>
    </TR>
  </TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2px solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>5
<FILENAME>ex99_2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.2</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><IMG SRC="transactlogo_small.jpg" ALT=""><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TransAct Technologies Announces Pricing of Underwritten
Public Offering of Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Hamden, CT &ndash; August 12, 2021 &ndash;
</B>TransAct Technologies Incorporated (Nasdaq: TACT) (&ldquo;TransAct,&rdquo; the &ldquo;Company,&rdquo; &ldquo;we&rdquo; or &ldquo;our&rdquo;),
a global leader in software-driven technology and printing solutions for high-growth markets, today announced the pricing of an underwritten
public offering of 732,500 newly issued shares of its common stock at a price of $14.50 per share. The proceeds to the Company from the
offering are expected to be approximately $10.6 million before deducting underwriting discounts and commissions and estimated offering
expenses payable by the Company. TransAct has also granted to the underwriters of the offering a 30-day option to purchase an additional
109,875 shares of common stock to cover overallotments in connection with the offering. The offering is expected to close on August 16,
2021, subject to customary closing conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Roth Capital Partners is acting as the sole book-running
manager for the offering, and Craig-Hallum Capital Group and Barrington Research Associates, Inc. are acting as co-managers for the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">TransAct intends to use the net proceeds from
the offering for working capital and other general corporate purposes, which may include funding the further development of TransAct&rsquo;s
food service technology business and related sales, marketing and product development efforts, technology improvements and personnel costs
in support of TransAct&rsquo;s growth strategy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A shelf registration statement relating to the
shares of common stock to be issued in the offering was filed with the Securities and Exchange Commission (the &ldquo;SEC&rdquo;) on August
17, 2020 and is effective, and an additional registration statement on Form S-3 was filed with the SEC on August 11, 2021 pursuant to
Rule 462(b) promulgated under the Securities Act of 1933, as amended, and became immediately effective. This press release shall not constitute
an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities
in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under
the securities laws of any such state or jurisdiction. A preliminary prospectus supplement and accompanying base prospectus relating to
and describing the terms of the offering have been filed with the SEC, and a final prospectus supplement and accompanying base prospectus
describing the final terms of the offering will be filed with the SEC and, when available, may be obtained from Roth Capital Partners,
LLC, 888 San Clemente, Suite 400, Newport Beach, CA 92660, by email at rothecm@roth.com or by telephone at (800) 678-9147, or by accessing
the SEC&rsquo;s website, www.sec.gov.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About TransAct Technologies Incorporated</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">TransAct Technologies Incorporated is a global
leader in developing software-driven technology and printing solutions for high-growth markets including food service, casino and gaming,
POS automation, and oil and gas. The Company&rsquo;s solutions are designed from the ground up based on customer requirements and are
sold under the BOHA! &trade;, AccuDate&trade;, EPICENTRAL&reg;, Epic, Ithaca&reg; and Printrex&reg; brands. TransAct has sold over 3.5
million printers, terminals and other hardware devices around the world and is committed to providing world-class service, spare parts
and accessories to support its installed product base. Through the TransAct Services Group, the Company also provides customers with a
complete range of supplies and consumable items both online at http://www.transactsupplies.com and through its direct sales team. TransAct
is headquartered in Hamden, CT. For more information, please visit http://www.transact-tech.com or call (203) 859-6800.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">TransAct&reg;, BOHA!&trade;, AccuDate&trade;,
Epic, EPICENTRAL&reg;, Ithaca&reg; and Printrex&reg; are trademarks of TransAct Technologies Incorporated. &copy;2021 TransAct Technologies
Incorporated. All rights reserved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward-Looking Statements </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain statements in this press release include
forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology, such as
&ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;expect,&rdquo; &ldquo;intend,&rdquo; &ldquo;estimate,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo;
&ldquo;project,&rdquo; &ldquo;plan&rdquo; or &ldquo;continue,&rdquo; or the negative thereof, or other similar words. All forward-looking
statements involve risks and uncertainties, including, but not limited to, the adverse effects of the COVID-19 pandemic, related vaccination
rates and the emergence of virus variants on our business, operations, financial condition, results of operations and capital resources,
including as a result of supply chain disruptions, shutdowns and/or operational restrictions imposed on our customers, an inability of
our customers to make payments on time or at all, diversion of management attention, necessary modifications to our business practices
and operations, cost cutting measures we have made and may continue to make, a possible future reduction in the value of goodwill or other
intangible assets, inadequate manufacturing capacity or a shortfall or excess of inventory as a result of difficulty in predicting manufacturing
requirements due to volatile economic conditions, price increases or decreased availability of component parts or raw materials, exchange
rate fluctuations, volatility of and decreases in trading prices of our common stock and the availability of needed financing on acceptable
terms or at all; our ability to successfully develop new products that garner customer acceptance and generate sales, both domestically
and internationally, in the face of substantial competition; our reliance on an unrelated third party to develop, maintain and host certain
web-based food service application software and develop and maintain selected components of our downloadable software applications pursuant
to a non-exclusive license agreement, and the risk that interruptions in our relationship with that third party could materially impair
our ability to provide services to our food service technology customers on a timely basis or at all and could require substantial expenditures
to find or develop alternative software products; our ability to successfully transition our business into the food service technology
market; our ability to fully remediate a previously disclosed material weakness in our internal control over financial reporting; risks
associated with potential future acquisitions; general economic conditions; our dependence on contract manufacturers for the assembly
of a large portion of our products in Asia; our dependence on significant suppliers; our ability to recruit and retain quality employees
as the Company grows; our dependence on third parties for sales outside the United States; our dependence on technology licenses from
third parties; marketplace acceptance of new products; risks associated with foreign operations; the availability of third-party components
at reasonable prices; price wars or other significant pricing pressures affecting the Company&rsquo;s products in the United States or
abroad; increased product costs or reduced customer demand for our products due to changes in U.S. policy that may result in trade wars
or tariffs; our ability to protect intellectual property; the effect of the United Kingdom&rsquo;s withdrawal from the European Union;
and other risk factors detailed in the Company&rsquo;s Annual Report on Form 10-K for the year ended December 31, 2020, and other reports
filed with the SEC. Actual results may differ materially from those discussed in, or implied by, the forward-looking statements. The forward-looking
statements speak only as of the date of this release, and the Company assumes no duty to update them to reflect new, changing or unanticipated
events or circumstances, except as required by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"># # #</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor Contact: </B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 34%">Bart Shuldman</TD>
    <TD STYLE="width: 36%">Michael Bowen</TD>
    <TD STYLE="width: 30%">Ryan Gardella</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Chairman and Chief Executive Officer</TD>
    <TD>ICR, Inc.</TD>
    <TD>ICR, Inc.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>TransAct Technologies Incorporated</TD>
    <TD>Michael.Bowen@icrinc.com&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD>Ryan.Gardella@icrinc.com</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>702-388-8180</TD>
    <TD>203-682-8299</TD>
    <TD>203-682-8240</TD></TR>
  </TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2px solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>6
<FILENAME>ex99_3.htm
<DESCRIPTION>EXHIBIT 99.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.3</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0; text-align: right"><IMG SRC="transactlogo_small.jpg" ALT="" STYLE="width: 315px; height: 71px"></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><B>TransAct Technologies Completes $10.6 Million Public Offering
of Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify"><B>Hamden, CT &ndash; August 16, 2021 &ndash; </B>TransAct Technologies
Incorporated (Nasdaq: TACT) (&ldquo;TransAct,&rdquo; the &ldquo;Company,&rdquo; &ldquo;we&rdquo; or &ldquo;our&rdquo;), a global leader
in software-driven technology and printing solutions for high-growth markets, today announced the closing of an underwritten public offering
of 732,500 newly issued shares of its common stock at a previously disclosed price of $14.50 per share. The proceeds to the Company from
the offering were approximately $10.6 million before deducting underwriting discounts and commissions and estimated offering expenses
payable by the Company. TransAct has also granted to the underwriters of the offering a 30-day option to purchase an additional 109,875
shares of common stock to cover overallotments in connection with the offering.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify">Roth Capital Partners acted as the sole book-running manager
for the offering, and Craig-Hallum Capital Group and Barrington Research acted as co-managers for the offering.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify">TransAct intends to use the net proceeds from the offering for
working capital and other general corporate purposes, which may include funding the further development of TransAct&rsquo;s food service
technology business and related sales, marketing and product development efforts, technology improvements and personnel costs in support
of TransAct&rsquo;s growth strategy.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify">A shelf registration statement relating to the shares of common
stock to be issued in the offering was filed with the Securities and Exchange Commission (the &ldquo;SEC&rdquo;) on August 17, 2020 and
is effective, and an additional registration statement on Form S-3 was filed with the SEC on August 11, 2021 pursuant to Rule 462(b) promulgated
under the Securities Act of 1933, as amended, and became immediately effective. This press release shall not constitute an offer to sell
or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any
state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities
laws of any such state or jurisdiction. A final prospectus supplement and accompanying base prospectus relating to and describing the
final terms of the offering have been filed with the SEC and may be obtained from Roth Capital Partners, LLC, 888 San Clemente, Suite
400, Newport Beach, CA 92660, by email at rothecm@roth.com or by telephone at (800) 678-9147, or by accessing the SEC&rsquo;s website,
www.sec.gov.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0"><B>About TransAct Technologies Incorporated</B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify">TransAct Technologies Incorporated is a global leader in developing
software-driven technology and printing solutions for high-growth markets including food service, casino and gaming, POS automation, and
oil and gas. The Company&rsquo;s solutions are designed from the ground up based on customer requirements and are sold under the BOHA!
&trade;, AccuDate&trade;, EPICENTRAL&reg;, Epic, Ithaca&reg; and Printrex&reg; brands. TransAct has sold over 3.5 million printers, terminals
and other hardware devices around the world and is committed to providing world-class service, spare parts and accessories to support
its installed product base. Through the TransAct Services Group, the Company also provides customers with a complete range of supplies
and consumable items both online at http://www.transactsupplies.com and through its direct sales team. TransAct is headquartered in Hamden,
CT. For more information, please visit http://www.transact-tech.com or call (203) 859-6800.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify">TransAct&reg;, BOHA!&trade;, AccuDate&trade;, Epic, EPICENTRAL&reg;,
Ithaca&reg; and Printrex&reg; are trademarks of TransAct Technologies Incorporated. &copy;2021 TRANSACT Technologies Incorporated. All
rights reserved.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0"><B>Forward-Looking Statements </B></P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify">Certain statements in this press release include forward-looking
statements. Forward-looking statements generally can be identified by the use of forward-looking terminology, such as &ldquo;may,&rdquo;
&ldquo;will,&rdquo; &ldquo;expect,&rdquo; &ldquo;intend,&rdquo; &ldquo;estimate,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo;
&ldquo;project,&rdquo; &ldquo;plan&rdquo; or &ldquo;continue,&rdquo; or the negative thereof, or other similar words. All forward-looking
statements involve risks and uncertainties, including, but not limited to, the adverse effects of the COVID-19 pandemic, related vaccination
rates and the emergence of virus variants on our business, operations, financial condition, results of operations and capital resources,
including as a result of supply chain disruptions, shutdowns and/or operational restrictions imposed on our customers, an inability of
our customers to make payments on time or at all, diversion of management attention, necessary modifications to our business practices
and operations, cost cutting measures we have made and may continue to make, a possible future reduction in the value of goodwill or other
intangible assets, inadequate manufacturing capacity or a shortfall or excess of inventory as a result of difficulty in predicting manufacturing
requirements due to volatile economic conditions, price increases or decreased availability of component parts or raw materials, exchange
rate fluctuations, volatility of and decreases in trading prices of our common stock and the availability of needed financing on acceptable
terms or at all; our ability to successfully develop new products that garner customer acceptance and generate sales, both domestically
and internationally, in the face of substantial competition; our reliance on an unrelated third party to develop, maintain and host certain
web-based food service application software and develop and maintain selected components of our downloadable software applications pursuant
to a non-exclusive license agreement, and the risk that interruptions in our relationship with that third party could materially impair
our ability to provide services to our food service technology customers on a timely basis or at all and could require substantial expenditures
to find or develop alternative software products; our ability to successfully transition our business into the food service technology
market; our ability to fully remediate a previously disclosed material weakness in our internal control over financial reporting; risks
associated with potential future acquisitions; general economic conditions; our dependence on contract manufacturers for the assembly
of a large portion of our products in Asia; our dependence on significant suppliers; our ability to recruit and retain quality employees
as the Company grows; our dependence on third parties for sales outside the United States; our dependence on technology licenses from
third parties; marketplace acceptance of new products; risks associated with foreign operations; the availability of third-party components
at reasonable prices; price wars or other significant pricing pressures affecting the Company&rsquo;s products in the United States or
abroad; increased product costs or reduced customer demand for our products due to changes in U.S. policy that may result in trade wars
or tariffs; our ability to protect intellectual property; the effect of the United Kingdom&rsquo;s withdrawal from the European Union;
and other risk factors detailed in the Company&rsquo;s Annual Report on Form 10-K for the year ended December 31, 2020, and other reports
filed with the SEC. Actual results may differ materially from those discussed in, or implied by, the forward-looking statements. The forward-looking
statements speak only as of the date of this release, and the Company assumes no duty to update them to reflect new, changing or unanticipated
events or circumstances, except as required by applicable law.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman; margin-top: 0pt; margin-bottom: 0pt; text-align: center"># # #</P>
<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0"><B>Investor Contact: </B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; width: 33%">Bart Shuldman</TD>
    <TD STYLE="white-space: nowrap; padding-left: 9pt; width: 33%">Michael Bowen</TD>
    <TD STYLE="white-space: nowrap; padding-left: 9pt; width: 34%">Ryan Gardella</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap">Chairman and Chief Executive Officer</TD>
    <TD STYLE="white-space: nowrap; padding-left: 9pt">ICR, Inc.</TD>
    <TD STYLE="white-space: nowrap; padding-left: 9pt">ICR, Inc.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap">TransAct Technologies Incorporated</TD>
    <TD STYLE="white-space: nowrap; padding-left: 9pt">Michael.Bowen@icrinc.com</TD>
    <TD STYLE="white-space: nowrap; padding-left: 9pt">Ryan.Gardella@icrinc.com</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap">702-388-8180</TD>
    <TD STYLE="white-space: nowrap; padding-left: 9pt">203-682-8299</TD>
    <TD STYLE="white-space: nowrap; padding-left: 9pt">203-682-8240</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2px solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>transactlogo_small.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 transactlogo_small.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!F17AI9@  34T *@    @ ! $:  4
M   !    /@$;  4    !    1@$H  ,    !  (   $Q  (    0    3@
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MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$
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M6$6K>)=8%R;"QDU.]@TZQ686D%S<$W%[<P6Z>7 _SR+G R1Z=7X^_P#!=O\
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MY)B\4FL3BLHRS$XB]^;V]?!4*M7FO?WO:3E?5ZGY%_\ !;O]H2?X!?\ !/\
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MSI7LN>*C4C[LXM_YROAS_D8-!_[#.E_^ET'^?\\?ZM/@O_D3O"G_ &+>A_\
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M>RSQ@XVQ])3Q7%-;%9/PLZE_]ECECH8_!N#DM(*MA\FPLIJS:PN(@_=G)/\
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MRZ76/$_CI=6TVUN;'6M<U]D22\66RDA:TLK=+;3-/1S'8V5L"^[SO%GCW*/
M[A#!Y'PIP\L%B\UHXRAD*PN%A1R? UJ?LEB\9BZRESU\;15>E6A1E&=7%U)0
MG6K1IQFWZ'A7P+FOC7Q5B\[XIS^6,PN55\'6SOZSB95LVQM*;F\-A,-2<73P
M^#J^PJ49UERT\/!2A1HN<HV^K?#/A[2/"/ASP_X4\/V,&EZ#X9T32O#^BZ;;
M)LM]/TG1K&#3M.LH$'W8;6SMH8(UR<(@%;$TJPQO*[*B1JSN['"HB L[,3P
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M3S#,:OU*,LCS9^RR[#VPN74DI89\KC@Z5#G2LG4<Y)+F/IO#_$<&\'<&\/\
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MRW Y*N1WK^<;_@VZ'_&<?C4GG'P)\5 ''_4S>$A^H&:_IU_X*]^$_P#A,O\
M@G!^U7IJQK+)IWP^B\3Q!L@*WA+Q#HOB1G^JQZ6Y'KT/!(/\JO\ P;O^,(/#
MO_!0BST&X>UC_P"$Z^$GQ!T*V:XF$4CWFG1Z;XFCALU+*)[F2#1;EC" S?9X
MYY57$1(X_"NV(^C9XM8:DN:O2QF:XBI%;^RCE&35G)]TJ>'K-7TO"26IU>*%
MZ'TB?"C$57RT*V%RVA3D]O:O-LUI\JTT;G7H1?3WXMG]Y]%%%?Q\?UL%%%%
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M\/3R^%-5NDWKH'C;2C_:'A76U(5G1;/5H+=;KRQOEL)KN 9$K"OP^_X-D/\
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MG56G7S/-*L*V+JTJ-/#TYSIT:="+C1I*-."5.E!6BE=IMZMGM\.\/Y9PMDN
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ME>S2"XM#%=;99&E0>60#\U_&OB3]H]?^"E7QNO\ X2?!#X5_&/5OA_\ LY?
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M+6KJZ^&WB+XL17,D5OJ<UGHOQ#'[*-V][KD:WS^)]=>PO)@/[6OM(CU3_1
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(0 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>tact-20210811.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.9a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +6Ips7xRiXgen8uNbH0sWaOBaaP9zJ1w6ZkhsG1+fbmqDyQmYJrKhyIltkqmAYsJ -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:TACT="http://transact-tech.com/20210811" elementFormDefault="qualified" targetNamespace="http://transact-tech.com/20210811">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://transact-tech.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="tact-20210811_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="tact-20210811_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>tact-20210811_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.9a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>tact-20210811_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.9a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://transact-tech.com/role/Cover" xlink:href="tact-20210811.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://transact-tech.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>daypitneylogo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 daypitneylogo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!F17AI9@  34T *@    @ ! $:  4
M   !    /@$;  4    !    1@$H  ,    !  (   $Q  (    0    3@
M      !@     0   &     !<&%I;G0N;F5T(#0N,"XU /_; $,  @$! @$!
M @(" @(" @(#!0,# P,#!@0$ P4'!@<'!P8'!P@)"PD(" H(!P<*#0H*"PP,
M# P'"0X/#0P."PP,#/_; $,! @(" P,#!@,#!@P(!P@,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#/_  !$( ",
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MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$
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M*F!7\O=N0?.%#>YK##T/;552O:_4VKUO94G4ML?ID[8'?GVH!QTY^@K\T/\
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M&-MBU9V\=I'Y<2+'&B@*BC"J.. *LT45(+9?UT04444 %%%% !1110 4444
G%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>daypitney_logosmall.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 daypitney_logosmall.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!H17AI9@  34T *@    @ ! $:  4
M   !    /@$;  4    !    1@$H  ,    !  (   $Q  (    1    3@
M      !@     0   &     !<&%I;G0N;F5T(#0N,BXQ,@  _]L 0P ! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$!_]L 0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@
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M$7#^=K"8+$X>.$KX.AB:,*F#IU9P;E4HU8\\I1<TYT743?P\_+LE;Y>\/?\
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(]3V^N4ZC_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>r8122108k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="tact-20210811.xsd" xlink:type="simple"/>
    <context id="From2021-08-11to2021-08-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001017303</identifier>
        </entity>
        <period>
            <startDate>2021-08-11</startDate>
            <endDate>2021-08-11</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2021-08-11to2021-08-11">0001017303</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2021-08-11to2021-08-11">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2021-08-11to2021-08-11">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2021-08-11to2021-08-11">2021-08-11</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2021-08-11to2021-08-11">TransAct Technologies Incorporated</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2021-08-11to2021-08-11">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2021-08-11to2021-08-11">0-21121</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2021-08-11to2021-08-11">06-1456680</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2021-08-11to2021-08-11">One Hamden Center</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2021-08-11to2021-08-11">2319 Whitney Ave</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3 contextRef="From2021-08-11to2021-08-11">Suite 3B</dei:EntityAddressAddressLine3>
    <dei:EntityAddressCityOrTown contextRef="From2021-08-11to2021-08-11">Hamden</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2021-08-11to2021-08-11">CT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2021-08-11to2021-08-11">06518</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2021-08-11to2021-08-11">(203)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2021-08-11to2021-08-11">859-6800</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2021-08-11to2021-08-11">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2021-08-11to2021-08-11">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2021-08-11to2021-08-11">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2021-08-11to2021-08-11">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2021-08-11to2021-08-11">Common stock, par value $.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2021-08-11to2021-08-11">TACT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2021-08-11to2021-08-11">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2021-08-11to2021-08-11">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140217897637944">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Aug. 11, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 11,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-21121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">TransAct Technologies Incorporated<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001017303<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">06-1456680<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One Hamden Center<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">2319 Whitney Ave<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">Suite 3B<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Hamden<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CT<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">06518<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(203)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">859-6800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TACT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 3 such as an Office Park</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>15
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MK+<O_-L3J[+B)7NA++RR%X>1X/ DN!O@\Z52=G_BWMO+GUU&_P%02P,$%
M  @ T8(04Y^@&_"Q @  X@P   T   !X;"]S='EL97,N>&ULW5=M:]LP$/XK
M0C]@;F)JXI$8MD!AL(U"\V%?E5AV!'KQ9+ES^NNGLVPG:75EW8>QS:')W3VZ
MNT=W)YFN6W>2_.'(N2.]DKK=T*-SS?LD:0]'KEC[SC1<>Z0R5C'G55LG;6,Y
M*UMP4C)9WMQDB6)"TV*M.W6G7$L.IM-N0V]H4JPKH\^6E :#7\H4)X],;NB6
M2;&W8EC+E)"G8%Z"X6"DL<1Y*GQ#%V!IGP*\"!JP'.,HH8T%8Q(RA._]N/P9
M,&FM5X64,\$E#89BW3#GN-5W7AD6#\87$!GEW:GQ#&O+3HOE+3T[##\^R=[8
MDMLYS8).IF(M>05TK*B/\.M,DP#HG%%>* 6KC68#A\EC%'S8 Y?R 5KXK;J*
MW5<D].)3"6T@L-5)](1&,80)"L2_C!9B7X2]_:VPI!&/QGWL_&[TH'_OC./W
MEE>B'_2^FO-CT1=X=-8T\O1!BEHK'O;^RPF+-9O\R-%8\>2SP:0<O(%;2AZY
M=>)P:?EA6;/CO9NFJ:]PSLM_D/.?K7/--;=,7I+VH_\W5_DMC)/Q]%P<T:L#
M.EL)7(0;^A7N5WGF0/:=D$[H43N*LN3ZQ3GUX1W;^PO\*KY?7_**==+M9G!#
MS_(77HI.Y?.J>ZC+N.HL?X;[:)'-M[#/)73)>UYN1]76^T$D7O!9QP<<GB-W
MPQ-',)^ Q1' L#P8 \PG>&%Y_J?]K-#]! SCMHHB*]1GA?H$KQBR'3Y8GKA/
M[I_X3O,\3;,,J^AV&V6PQ>J69? 7CX9Q P\L#V1Z6ZWQ;N,3\OH<8#U];4*P
MG>*3B.T4KS4@\;J!1Y['NXWE 0^L"]CL0/YX'IBIN$^:0E<Q;M@)QI$\QQ"8
MQ?B,9AE2G0P^\?Y@IR1-\SR. !9GD*88 J<11S &P %#TG1X#SY['R73>RHY
M_U=3_ 102P,$%     @ T8(04Y>*NQS     $P(   L   !?<F5L<R\N<F5L
M<YV2N6[#, Q ?\70GC 'T"&(,V7Q%@3Y 5:B#]@2!8I%G;^OVJ5QD L9>3T\
M$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA]) 1-MC0[!:+#Y
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M4')O<',O8V]R92YX;6Q02P$"% ,4    " #1@A!3F5R<(Q &  "<)P  $P
M            @ '+ 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (
M -&"$%. QO- 7P0  ((1   8              " @0P(  !X;"]W;W)K<VAE
M971S+W-H965T,2YX;6Q02P$"% ,4    " #1@A!3GZ ;\+$"  #B#   #0
M            @ &A#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( -&"$%.7
MBKL<P    !,"   +              "  7T/  !?<F5L<R\N<F5L<U!+ 0(4
M Q0    ( -&"$%.JQ"(6,P$  "("   /              "  680  !X;"]W
M;W)K8F]O:RYX;6Q02P$"% ,4    " #1@A!3)!Z;HJT   #X 0  &@
M        @ '&$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M    " #1@A!399!YDAD!  #/ P  $P              @ &K$@  6T-O;G1E
C;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  #U$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="r8122108k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://transact-tech.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="r8122108k.htm">r8122108k.htm</File>
    <File>ex1_1.htm</File>
    <File>ex5_1.htm</File>
    <File>ex99_2.htm</File>
    <File>ex99_3.htm</File>
    <File>tact-20210811.xsd</File>
    <File>tact-20210811_lab.xml</File>
    <File>tact-20210811_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>transactlogo_small.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>20
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "r8122108k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "r8122108k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "tact-20210811_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "tact-20210811_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "tact-20210811.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_ref.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_doc.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "TACT",
   "nsuri": "http://transact-tech.com/20210811",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "r8122108k.htm",
      "contextRef": "From2021-08-11to2021-08-11",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://transact-tech.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "r8122108k.htm",
      "contextRef": "From2021-08-11to2021-08-11",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r9",
      "r11",
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://transact-tech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r10": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r11": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r12": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r13": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r14": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r15": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r16": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "Section",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>21
<FILENAME>0001214659-21-008684-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001214659-21-008684-xbrl.zip
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MZ\X#HOOW3L^#N\=P0WQ/)\MP)5MH("-UZV!X;2?^C4Y\:# \*Y<H;OJ,WE_
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MYC-K[_IZ4_C9,*D]B;3?;M0K91P282)!+R?"V.LE)C8Y"I<(#$#(4OUYP>*
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MD328LW>]84M!405BR]3%6^W:V!BV8KYV;#NVW4[&HYW=$91=&#<<2(IWAJ7
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MJYHHW/)CDR-))O $!D#K3HUY-]*$N?F0XX*V&2/%CK99'L<'FV.'0Z;:R^9
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M3,Y.#RF3+YHR.3L]Y$P..9.O2EU\OJ/T:G_,O01F>N$/IHB]CK"9D?#"?D1
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M:8/%VV18I^F TL)-2S.:.-!6PG'U_X_<.MQ:3Y5[Y76V+"M:FE_!^%WA:>2
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MA(;[JW"H>%./3-M 8:"TOK^" OO4N;J)";RZ,*:!QP=;FFLX)"'KUY_:5Y(
MLN00V9!0ELDWX)[EXIDA]IK8R1P1C[N*^?:56L)MTL0U>FAWJX6!K#(:EFL)
M 2^![7/JQD'_6RWB+ZBXQ1'G9,ZAQ1_U]IW!HV=SDTDN:LN*O-U]M&>2'!<W
M-2VE9LSD2[N0O7Q%2<;;%:N?SW>V$23.@KM/>ZC'RI!'#)'$"=A")'",VOV!
M#0X=^A$K3*A5)C5;H>H".?P]XSC<,%WDA43I!WNM(MNX%U4*_,#("CG^#;1!
MR2@-Z_2ZEQ(T9&00Y6SI2GMI2M&,DO*6AO_-&2U7^MI*13G2P+(*6Q2U%4A(
M,5BZ7I"IT,+WZDY+:(BG,ZP<S[G=X*T1<=-R+BZ:-;(K#89=TH0SQLMS[0]^
M:YNL5M%3[)7]YMTZ4NHVEUR$<]DE^#U;I+/9/1O/RR(%N875>>WIY\^E4!C$
MXF4Q/;&L&+^\_.WU><C]U"\#1"W"F+!N0>IMVOJ+16?KO^U6A 9%IZT(J1:)
MT0+2!-,J=*O2O$GA_(' 3: $#NYNV -3B73JH6%*R]K493:WU^%__ 1=;%H&
MFB>XHYZH0781.6$,B*!%( /F9^G:H_G6SP&US2V2Q*+8V=?0_.EXM 0#$^=2
MZW.XLF3!9H7PEYG.QK^\?!9H!X.D6&1)(3V;Q1_DYY[=??R#JH<_"DK9D!S5
MH'PDN_>:@^P85DEI$<\>/WH8\EK:4NOV=C"-\-(RXU?CE"QK8ZJI22(<O$-7
MK)'140J$G\.)MYC )KEW%D=W3^^>.3-?\@1X\;<64+]W"*A_V8#ZO4- _1!0
M_ZK4Q6=LP[M/']ZC_'@\>B'AB)W#%&RPFRC%()36,6N2R1Q[5DU#LZYP12&2
MRZ(54K<W:#RQO0/V$T<*7%U"PGS7Y?M\J@QUT\RAJYK,=>RZS)(Y=RE@Z-U5
M7I7D<=F3]87_&&[\*PS1GK/CD? 7H=48,,+;$(( "8?B*[T!@$[AWE2B&?AW
M+[W06EJLYE6J#$LS2FO4-:CF+.7N:.*J=%_KB4 %LWT7/!PM$O;X>E6J!*@=
MZ7YMVHZ)CVV(%.CF,CXSF=VA2JPF76$]<1"J<0ZC#@']TRZ5*\?+N"Q9H &.
M1(5#:-(;0,9-1KP,^(F4(&PU>2B[@'(NX: Y+!#%NCB.1$$Q;3HQG&\(IIJJ
M,MYE:OYX!$4?9J&5=0BF<3SB)2>$*+Q-47KZ+=>,6LI)V3='!DR8CXQQC171
M=2SSKC<_),\2T.)PB;3'CMZL,"I K59K,$ [1--XTRJ[Q$J!J[8@O.: .DPT
M7@67N+#%KZ[E(I7/DM5Z:JW6Z.C^W>B/DS<GSTY<#N7QP],S; [8G("O]??)
ML=4!SUZ\?O9KZ'V'KE'KM8@CECNII!&]6$>H.:J -;)4B0^J+P@4>I:*G0*%
M1;+09RL.JVPR)>9TJ8<Y)[C6BL?B4?';W2:';+G<JP[<9UHHVB45*4&H ".]
MK%""DK>Z+I'76<N/>C39<!N1/C@15EVYE"#7E;5S@OA350<>.HOI&ZL;G,Y%
MMPM9](L[JR7VS^1H 0A;V%NEK41[E(GKM;)!=\82_N1@(1&65%@Z45-(S@W5
M(P<=WX^3YV""F5Q6SCOXX!C#.=HE<0,6>$_*J^@3@+B^F<WR]]][1R\*)$_;
MD#MT],<#M'D.+L&;0_6Z4# ZIO8 #;DI^\B)L#8:,LA*%:HXNW$6U9;](17\
M\Z7_C4Z%.WGN!R?/>'2$/_!'2_]/;YCR^)N1M:K:.5VS,:L6M'O?@0F0#EBZ
M'>@@S&*V-3?UEF%J/B2KNTSFLP&8B'\TIFDVPC>X8)3CQ"Y[#!]?2(A84\L]
M3^H>#'!0#3)6D9<RSW9YA8[JPPJ.52U^B.??1*.-JX)6!1@OLY64 N23E23(
M+_(9Y<<Q4H-Y'=?4AB?:_4S!NT%E&J:PI:L[GP5K]J%X[24YM/8WT6YT2'K4
M[<EK_"6>9M#['-XV%(K5T(_]6.24830P3!E<6;-3UIH8]:6DV5?:@?QP,H@?
MAK9>5:U@I[QRK0^<^OCA!ZL^J%,"N1]N"EJS*1-QFY1&76\]H *R@="^[B=(
MJ#*!BFD'+'$W<2F9(:&A=^EK%>(M.HO^P<J-=UFVU&.OTF)G5Z(8@/N>D<\X
MY?&)H$1O;2[65TM[83D-8_-<.U9DF*<D6Y^8>KBK'?N[\")_K:J\3KF/>2TT
MA/TY3#IVQ9,1LTQ-N=(T0>)@3I#\K$RQ<^S:/&GJFUH1X&;DI@/H4N*)W0YS
M<._M(PQ-,S9GS@D[<YK^BU[V5_^R[7A-)/U->!*Q<"MO!/HD[,Z2J^< +0\#
M^QHU'39L'D_LPR_<82MU)T%237),T#$M6#F_:F&6-CGZ+6X!7I7>MV/"!:$9
M\UFWX;/.<['>)B71-#=C6?0M5K&SC3%TVL?FK*\L4VG[?&:!' B[NCB3:6A&
MC\50!]C96LL;[#L)W_Q.X\$[J[(Y9WJ,9US@YQ*%>*NWZ%FMT,)YCJ7&33MF
M^OLOYT$V\HFSZ/5-G.W=;[&@Q<%X7#7YY?'J.3#]6H:Y1V=V9*V$-47*DJL$
MM!)%7 R+>ZTSXZVU./H+D> 1=I=%%QC?J^!*R\ R)#W5$$;#%82O*L)->J(5
MBE=?9M:1E>BBW.5#EPIG]EM+>-X_)#R_;,+S_B'A>4AX?E7JXC.V$UM]EK+:
M(%Z,YQJU0RTKWZ;/-J0-N_L:3I,Z?W\'#/;F4H@^J"_NE.W2$$L5CL %&OA!
M"5KO-I?"M#+W[Y^;/N:OC8'^'#]XXXC8WGBP(Y6AT %(H=5"WZ*G,Z@S829@
M7,Z0A S;A,;1WRM8IUGNNAAR'\R:O^[R$Y!#Y=(Y[B)]$B6"NTU-T>/@SHD(
MM.7^IK<*[GAUM5=.8[::@Y$Y)W''29O,E;38\V5YQAPT0A:K!04WQ(<L4NI%
MZ4%E5&-DK<07NJ"OLT;<6VJ0O' "9L*D/]P?CVS6_?7+-^<=QXU<4R.VE-)?
M"04-<U+ ?FFZ[FJ;JHURV9HI PG3$.\ /\&]HWO'.$P:%0>MA>YVQZ&XLANJ
M=W Q)ZJ_@8G/)?W#5$?YDOO#*R4X&Z[85W1/: 4;T(3+Y%)'C4NX2%2]SUL)
M-YY_K9,(# R918Y&<+[^BGC].I0/.%IZUG'8[Z&/1T_N^DH(SE^9-8([,EM,
M>,N H,B)^M0P;F.7&,T,WR;-<'V]@9QO8Y&;9WOQ_&%--KTLRGEYL78$BBBI
M?Z_R)0-R4#Q7#8&@F7P3_E%DS759O:,P=94B.1!\6<X:_M=U-L$D.195^82/
M5E$E(%0)AH=;@1^30@'+C1\4*@R,X:4P,(K*HL^-]^-((&\OI2\9YOKSB=+!
MFHN F\A6V^W&Q&J]=A=C!->RV^'<C' \FJPN,+9>5=3N!'8#CA?DI2K_ CUQ
M"9_B=%)3@$FYF,"_%VAY2UB3#]PI1YWIH.RPJ_9@#9 X##0/*7+N/(Q(GUS;
MX6)5,S:^%LB!8TY5AJ#8U:7%AN4JEAS@#+0.'2@!\:B';$EUK4>\E 46"%)*
M&-?&"ZCKS06CO.!B"JGK*A'EKLN%$<H43H=$@ZRVSP5.MA>K2 719-^Y>)&<
M>4QKZ[\0(L##FN74K!YN6V#Q^%46!V/F/AFD:3.]N8%SR^VBY_"%E6K)Q?3+
M(LR/J59T2<\J,W'LHHS0(9M>XM2[]O:8O%\UR44FQ2RFM_:J9IN5,F!3KB*%
M-<+6"+;^)N*&\9X AIZ&IWZ:X^[1_)=9P%JH[16L(]&4=,4D6T16O^ZDYF*'
MB$%"P91BYGS(.TZJ*KO*08=VVS%TP(3X%CO(/NX;?Y :=-E.?<*EAHAB[MJ+
MXJ]5>D'Q?JTL0_MUJ' HB$&;J'([(NU%"IV6Q!<3N9EQU;8"?:-^8"O\J;?_
M,!\14D0NJ_PJZ=DEK1T2"&TD),(2Q#.H2S(R-OZ4,FI6",<C0GVR_($JRVM?
MY:R];<K4%;+?IL/]_5Z-]LHBZQ89=5@-@L9:ETPL*"'6U+=)\A^&]3YS*FL2
M[C^N>8,S5I =S^9E394=2%TH>-4L^GW)54P]UT3"87G,6RVS)ZT;@?F,[R$9
M?869F.+9/KU);*4; 2FE) 02;C;X"G9(COB^(#80]P8&!IJ"^V-8!X>J0#TO
MSZ MX?G0(]?M6V-DN&CX11P9Q%%RC"78Y?6W%BA^< @4?]E \8-#H/@0*/ZJ
MU,5G;%^Y)B\YLN?EGQ:T17:CJY_/1'M7IO)5(R82?D1E34APC52$%;#=GA<;
M*BRN$&7<C$<.4"1M;]L^*QN8':*0[24X+:.UE[4"S_[A!/10T8KV5E/2W:2)
M0_0\>0I)>I77A*K&[W-'L]%O;$M+#9JX<."^]T@8D3?T)+@T$F0C=R6QG7>G
M.3*@NIJA 0I+M)&E<Z,ELG3^E%KMX>!NAUUZ>O( GWSO9'>[=)?_Q3(,5ZOC
MC-@_T//#8G0P535:];OW9=!U9O_..#A1SV]=K#ODQ:B0^.&*:ND9.-0P2H#O
MZ5F"8#Q;[H_1W54UO4P$V*!(YRJS" !;>S4#0Z.\)C>LIUKIQR^QIE],.2=[
M.3F>TDS* 3;8X5Q"0TD)SX]?7Z)*M&$,WRVRZ=(=]/ WM^X X^!NEMP_LZ<_
M2!^]<V#1][.VM,Z GEZ=87G6>-1)"]Z_=^\H/5:I>TU!B/8$?,CH.9FPNEW%
M$I,]FV"3=X&Q)<R92.?W>E5KA_2&"U[U.-G-[U1<H803*92L?!U+=]50.H5E
MXO1!(!#''8G <=)'$[(N,M]0O<!.R/A6K??H],9H[\KQR&_+X7M[I";#SSD[
M)@@L]S-],'L3'%IT+>C]EA#QC0V>%7R>&O,@U$;*=5D-4B#]7)&Z%8YX][G.
M11OY6KJL*X%M=#P>M2>>C2"W#36.B62AR=1&0LR05$&%>NLD>MEE<LOFKDBJ
MPBV_6I8L$^/1_7NGYW$P$2BW>;FJ$;XG\0J*W07+/?3F/8KH]+RK>1#R+/?F
MER7HMK[9S/-L=>]W]S[L1UNV@V\OU4*4&F&01<=B-&.0WB]@F^-_B"%=I[I$
M_&,__XU&.;W:5,AB$H&<-G?\Y!!6F^>#'N5ZJ=IY;D\*7+I8-DXA4R:&R<>R
M-&CSLKUC +*XZ^3?)D4]W9=8>(NCUTKV;?#[O))J]\;VOLOFA[5#N.VG98;7
M-:N5!ZZ%UO'8AO1X>$B#GB.U(BDP 2@\;:)FN&D-V;$VCHN?YS/'OL9MD?#S
M(]UATL*$?AF^OGW[-5\E+UP;YXOX#Q1J5&U_(YODU?UJ1WP<YH6L3G!$=O@1
MLC 622%Y\$176=+7RN(L7<HO,TLXL$E(VCV=W#/QR',WY>[E2>,K%KHO\JU%
M@1\>HL!?-@K\\! %/D2!ORIU\1D;F>YK%K0L/W-,N* !G& ]YZ$]H[$4+JT0
M6^%RYD'P2/ G6=K5[K$K:)Q>YMG,MV",; =&.GCH^V[W12QFI:],7V3W76AG
M=$.Y/[HL;\MDP9IC;QV%1V/[MMW3C]H+=DYN8H%V!D?2=\F0N0*G<?\Q?Z,&
M2+2#_4% LIT,$&&-:GMHNYD?4=?ZZ+,\QB.F\=6"Y09IX4E\IS"_R+J+L7'D
MLLG4A1RF'6V')#;1D*K#C35?,/TK1'&]1$QY%?V" 8L_)6 10N]-GX5RF1?D
M;I\?1T=GQZ9;X@OG /$&V>!]ISD'=1730#D6F1PI,*?UJ[V_/K,!?_0#R6''
MGMN(BFH86[AN7=*RYN@R1Z%,S?P<#3G]362P2O9$#K[OVJV_(A+RO)YG"==^
M'MVUDY!R>H-Y,M#Q#+_A+SJ1(YT//P7H62IUYP=.C+CN,C>M:[HO'O6_-Q74
MX8NK#$3SG(C.^:W"O(V@OEO]2E%UQ)UY(X#)/3MWYSYK@X=*[(C;CGYZ^?/[
MG[Y_^;.<$LVV/IH(EL$?K<V/0JF/-@L]NUF,]4@SEJ +;@'I_'D9P'C4-P(7
MAKK)1=LHSH3JV7E9HT^WJN/1T5-P;7,T7OOT0E%&%'9MH='I]O6E!XY3R"7@
M7TY 6R\%"1OF,MW,(%)(0SLF3#2L/'?C9!;RN0)7IES>0*#548BY0B5'YPM*
M-F2S:X=>Z234T*N?*FPXD3<KH04@[*2,SA>4>#S3>*2 )N2A4[@J*QRW*'X1
M^]FD0Y4KG5XCZ20I@J4-.PQ_5&Q8KF)2_'Q 1D?&3++AV)A!I6+P]'82]/!O
MC\9U8?<=>P::[7X[.:>RFS?#V5*M\P4L6E)D'+7NZ9S0(UL1]U<'WP1;WG"(
MVV9JS[&K5TE]7W8TXX<EF?2@-%5-/7VI12'8"'0_ 7OLC!@E_#!&89#)D!X/
MZR7F2%+,+.6$</:Y"_$*T,34!+LDEJ;E C6B3(M+*,&(5N:M!:IAZGLHN>WV
M5VMT4R8+,A?8\78"G1O0E?T6Z'@4F*!D8?<Y:/'NR]YUWGKRPYUUE[HN^\RC
M^OA&EC_:9_'A</J$J]\I[AI:? Z7WNSJ^V/S-NG.V><*8="&>)Z P9(W1$SS
MZRNL<5D5=39WW!B&_L2Y;-QKZD(V1RW]C,8C%J6/"H;(CA'B4Q$3WD]-@U4O
M*;D^B *KHQ?OJ55U]#0Z4JN/Z(LG 29G"G,-RU-1O=MJH=7&7/JBW8.5U(V'
M)V$ *62[50Q^%Y]5^EZ!TUY/5K V?^9%<PG&' *KKE$B&WBG?I&TTF3E,NXY
MOP<U>8_LM54=72)M\K1[7^M^V*/(J';Q'GSI5E_Z:;:J"JXR9MXJSD]S;8Q[
MK+XS)]K*J?1_XU$XF --28;/%M]AP57(<"/,^\L1):_PK>61?CCDD;YL'NF'
M0Q[ID$?ZJM3%YSL&+_<X!L_1YK"Q%6:;'J@WM]5IMK).3XRPEBYQ/?N"-GTN
M.S'@5U"2HL<-&3X5,8@AA\YM,G?V[D^^@[DS!7O$(XI^+:?O[JR6/D)02[""
MX1]D&#$AG319Q"J'.18&DN'T!FU>!'B!>F3+]S8MSU_[+H]LFS;@COGKA2Y_
M+J4B @/M:\,>.P>B+*A@Q-$.:U4,5M#4",::WJK WKL;V2]]BBN7XB$3*S9=
MG%-"PG&*1YAX3& AKY&GGG7NACB]]&GO"=1ORW?VE0A(XKS2E\* MY$X&] .
M MGC44@?MHV&7#_IOQNFHK()*(L^RI)ASE.8"PJ=]36HI'81YK!Q11/[)3^V
MSFDIG5+L3XK2OV<I#5S1U6MP2EU$UW&.F>:VG3U/IB]S.94[-+F14A-?MH;7
M2U2-Z1L8QV_S SOUJNBM-$/N$AZVQCBX(U"65!CVZT!$8\GOP_Q@LWGB-T\6
M.(M'UY><3\2L'8V<>MJ[!D>N+=!6.6M/8 UZ0$ &0@M"+NNV]V6R)E"D\JKG
MDLUY(3U_-0$VSRYX?4-6YD%B9^Q(08FQD(4Y'A)Q(_V<##/JQ#1'T54?ZB<R
MO(>$_@ K$&E@]2ZSDRCVIM69N;OC>C#'?3DZ&84KC@@S<?NIIJTYMFB'%!L-
MZ"9S;'U=#7HS;+P8F*2NJ6U]OE@R(3^/$<:+1:J$"W 'A3V=7!,P97>A: H+
MH&%DTS) ?&WEG6CU/PG7DT$ZDR]'6O;%S(7Y)S"O/SP-N#MBSW&7;<GU*<QA
M")K72A9O>N1 Y@@+%_;)'':BF)J2N8$T7!]"97L6SLSZC<[7D(_[N>?+HC%N
M=^9JL>]NWQ8=GR:KVI?#NF_ZHQ@4ZX:+R!@*"FBH&4P80F_]."C3:P7T,W3%
MO[7@^:-#\/S+!L\?'8+GA^#Y5Z4N/MLY\%(9#]55P*.0"<1S8G0 &TJK%_O\
M$T=MS=A9J4ILDR/H17''*--#V%-Z]#%Z$*@SH/2PT7@X,H) ?*SGQC2I.>T[
MR6+Y+_%[2+/8?H()^%2#&"&ICF-U$!H;JFI.Q/$UG'P=2KV NA.9I0MJKTFE
M[@*&QVYB3!7:9[ER?;,,W*T$82=\JSO'["F]3Z@IM3 \"Z<G?A2;,))+:!OZ
M;2SC?A+Y.HW+\AI)6:1@0ZZJZ;(X>A!'#\&V^X&6\;$("%B<5[EP0'=&SHR;
M"S;:4# (*C 5"F[RMV^'%28L+_=OC+F'.'ND/H5=(E[U\\%2(-U[=J<1B<]7
M0'>SV\'VY\OG;__S_WQ'9]3-Z6ZCJK?9,]_]C&-MFP=G)W?IG0:L!WGCH^2X
M?4'/;'WW\]N@^+Q3@416,O,7(5%1^_0-UW&'5V:;;I<9O/%]0__+D[>'Y.R?
M%PP:8R'E"X:L#(OV!.$ZH(S*JN'.[HFVR!J*J^<S.A<-U82$#?&,*&>;8AT"
M0*(-J44,4JG1E#&?H"W*)%;=S$J!_RYKZC?>5T0/1]LRD9[W_8PVS ELVO=2
M\)M]=<W$]9^41Z3=M=TT30"?]ZO"N&5X0EUFW* ES>;)&N/=^$SDT^ #P@PF
MZ#QBF47ZRAF(GA4?RS2X1!DK"DXX2UR4$",AK90 7UMG:/OXCU,P$PP;&(J+
M7SP*-#'#P[HWQ%1Q0P]7TR1G=Y94<RQ49).A5EO$F4DZOTC_$ZXBB2C.E$"[
MP]=C[O2-14W<-]/)(KX!;,."V!3EZ3RU3$:E!%55=/;P'LS[T=WCP)Q"$@H<
M^\V=$1^VZ;\2S;./ZGE.K8<XKRED.!-0)T5A\MNF7I M(FF[(^5:RO;<-C,C
MY69*A?[#[+\T8_MK:!OS@,P6I*Q:-"^+"RLD$^QK>BT;W+.<] !GN"/2!.T+
M"T_G_0_?55&K+;=5/L]U=[VB&;)T_"&'IZHW58-$:=FGI; =C.P*+%\5-V4]
MS VD'4 'XJQ!=B=4S+%/U+F*-7$*ANGJF%<HCK!^3FQWB62!@=\FSQ(7PAP5
M?35GVRBOW$UZ*;=@*,\<19WB)OK&(J/]B.*X<*!RO\TT;;PVAJ=M:4ZUY9Z\
M;'&W%]$@+5NL<ZGI/ HGFWR>I):D^[1VN.W4[E$,_KF;8$J5@/)I)[UGCM95
ML>V]Y1T\,36/A>\8 .);R2XB<4LXIX;WM_V(_?O!-"7^DVUO9TGA3B*KY8S4
MM?9UWU[&@YQL@CWE>]-FHP6B9K 24\:"&VT?3DJMRF99E0EO[^8'X7VVE,VO
MBCDAP\W+<0,P"8</D9@E"$1;TW2R+4I--5Q805C7*'?2G2MMMHH+D-J9:\^-
MJ^;MY.[,>5$2EJKN,R9W,)5EVP:ZPRD*'*?1%A@:(1I^[5&-T*T)5[V#FBS+
MPEJW=$O< FF57"=SMI#+V;<6[']\"/9_V6#_XT.P_Q#L_ZK4Q1=S7O;Q7E[.
MXC#RS8:T-;G:K8S$YC@BKQAQTME*M3:?_Q)?IR-8L@5J?9W]<,\1,3M>W-RV
MB&M[(H,! D?(RE8<,=#3&46,!S5CD@3XYQ"K+?.%/6"AF1!B0'>T4LLM@I))
M->]-LMEX<H_MG!YL==T0J0>:(HBC\S#@8"@T$VT3HV5[8>@,&70-Z*>U-F)R
MRM)8L\EY=F$<RP6.>J(A'@BNQC'%=L8CM',R,43@+LE%E2PO!0@C01Q+_QT'
MA"*M=S3%JXX(2PP;Z\HX'ZEJL9/8WPNWEQ01:K^%0VB%M-/57LHIU$T^@!?:
MH-O,=\9AJEXH5$]@X.(JFY=+Q@WUZ0MNM$9W'X^&;L]* CL3SO-IXT7X0^!>
M#K[J=4Y'Y9!+V*-S^(<MS?/Q+%K;-)1K]KU!0Z'_D(BWTXB'.ZG)2&MH;;N*
MRFH-"I<ZU2%=#?MB7L0R%US<H]!B' ,U:+LN"!A<U!K1W29(9211"0[.!9I"
M!0 FI'M(>-UQT /4:OOC<&HDCQ<,B<1%1N%*I ,T 96UQ>)E.4^5\6# 1S<^
MJ4"5*<(_6762$/<?C$<I6/91,FO$*"'A8HD_NQOTG3=18!%Y<^TLKQ$1_?<J
MJ9HNZ%*ZV7N3):3=$DTV'H$)%CT^C6A(N= ?MD<Q+;G'9QT<K?@8ET21P:RS
MI.)#4BL@C  +NT.19<QN![HC0>Z6+#WNUDE@.K-R+.RM$<7!6<OP4-[,84MM
M/;K/SHS%V&,#LEWYX)$;!J=;#KL,=]D'YU!Y=23 M:%F=3,QA,)8IN R(%V0
ML &%U9G])R$61P6-@C-F&G$Y5$Z5MU*KY>P8#,"9!XT>Z\YG$ Y!)\P8NT.4
MD-T6RK<C_5E[5+V/I^9@G9$RAJCFG R'JGT*,O# ..EBADWQ3\FZ#"0=-UKD
ME*LDW($NQ*;6*-L#I)YLHY6 [DM_2P[,G\=F27=E^(#)I=8;-B5+ =!=1"O^
MB#=MI=4CUW/..Q9$FQBZ3_1R'?!T0,E#5@OV/*'FUE-?!$7=1*JRP,^P#M8T
M\Y"7U5D=;"T4=BQZ\?R?YZ\=7DR?\IZZH 9-4U^[%LK1FSMOO[&([-W30T3V
MBT9D[YX>(K*'B.Q7I2Z^F!7VD6;8M.3*31,>VTP?0BV_8!3)55E)Y);3Q^MV
MUIBJ)R/7LCO ?1ALDBNR].%8[!3J2-=MPGD341?X(3!A'!)-=TX_(CHI9]YL
M>EK(#6?ZFQECRME#:ID.=SH?QD5WLMGCD3@_[O8A4H:.8IRUF.-)'H#O(^1^
M+>@25% P)Y'FKS5!7RI'"5PCGBZ5W"J6I<ZJ*V'!H,Q]70]E_S5\"I.<S6=T
MXB?O!;<-5F=)3=X4*-=SCX,O);OX0[=QK!Z]P8A1GJ5E,1]QU?:-9E1(5CX@
MHZ(>PXOW4IY^CL0!#K<H[1>6M$,]*MW7^/4UTNP'._9UU#J[%T=G]PFOZ. Z
M=B2V(YUI0U=WW*#@1_*"6,^KEBU#;E?S"Q\'I?DYR#Q%Z]_O(?'2Z5N0D(1Q
MT8H;U5O.+0OK?V?<U8\W!ERC,2T?9O/%W]T6&5VXT1%E@&"OQ.#Y"/<Z@5'
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M=)U.=AI$8-&T,D"[(IO-P:UN$UE5^Z.<HSU!SK5#.7-'>[;Z0&!6S$M"2(E
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M*IZ5\UJ *,L^4$V%P-DX'S0<XJ&^Y9(]9*.>@'P[Y^X<0^ "S(91)$J6;E'
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MP$Z,_<QV8M;T?4*\]O%E8?/V,+YD_#]02P,$%     @ T8(04S[$#=C;$
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MSPI&E;(!A-/;+3HZL[AJ+I=RG"@Q7C8YQG6".<TDJ"36B"F>>&9IY8H!5;#
MZ%E].W'4[Y**3$Z:I#UY542@I4@Y,HXU/9=)NW70/^V<O'W3$/V:V+$S,G.(
MF7X "$V9*KHH["DR60;Y$?V%AG4T.7#Z6/&C[9JPH\2 $>P+'G4,BR67Z@A;
MC;]@':_"*SAPL>3U1 8G.L9M[_=&@#\&9^X-Y'8I<UW"4^]D46:D34A+.BN#
M[DFJ\$A8B#&/W:+*,C8@'"BG4 NY:%/P'3:YRT+J:?<C]%6E*_H?"E/E_/I"
M%K2VA ;NE542EB&&UII(PTQQ Z!6CSVD9B,R77^D?7;F_X@R5BX''%290Y$*
M=DI7S519HPO!2;NUYG DDH4I'ME*O;Q)TM OE#15&3F/6,4"\L8</@ &%S,=
M$;(" [,HJ6(E)G!MHD,'3*J"*<1JKA*3D^^1BP967Q26 -^V6Q-C )^JF!-
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MB8\NHBJU[,<NV8-3$V<^B'&)[.,[>5TB%W^V9L?V]N?_"?S_)[L)MVUN4%$
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MLUU8HB $S<[)37F %XL91XO'TNVMA1IW?1?>'@;0%5Q2S=VJR4.PEE>,#ZA
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MJ?38T?6M:USO=;Q.@!"O]#I>Z1/ ;5234<\9WCBX9B![@ 3\>^@!(2<=H%!
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MF;;IG(56M50SC <VXA^!:LT,U7IT?**S:9:4A_M(Z'WY*MBV^?'XJKDT$BY
M .BY63(V&IN;S>HC20K_"9YG+Y9*[S6I4>B1<_#$ S"L@2-L1[GJL*'LF8',
MP3II+5Q_4#Z6BV.'CT:.P/-BT@<9)IXD^FMC<5*^*G?+A(U\ET^ 5$Y&$(C'
MRW,839E<D3M3Z^4VPJF[E][:?^+]L%%]78O<MNV ":%_G,(T1KY=.3H^K7_^
M4M]FO+XTNY(S>:%UX3'REHY S$A'KO$;K?63*1H+U(]CKNYW:>:I6,MGX?#L
MHO'5^.1L?=E\01;6"JU:W=@F'X=.Z+$):=\N\E**<QFRY@,+J^<O[.-G8^OM
MYGF-O>^_X,) [KN1 ]M&??_1"VKG+:@#OUX$/7[GY2_'.=LXYT8@-K\TEKV<
MZ=2%EE*R1R\E5^CD/GH17((G"WOE @?ZKCZX/-OJ'(5?K66O9V;^0JO3>ZZY
M>%&-/<HCWB6',,#]Y/B+8X_3VZ.M03"N.F?VLDF7F1U=N8;1_,F\.+T2]-C\
M /CO^-0E;,RL*'1N,3, ;@H3K^TQ 4D)TO1[^D6OE=N=YHW^\Z]FS=C:%=#3
M9?Z0>['#6B3 &3="MVMU!4)6"H*+)%YD*M%$M:';8J78;']V>H>]_<^;RTB
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M@P&A]&CBIPY%L2*$;-0:6D2RAZ'R"'3-V"*=HRM2JU?+T'']!^1??";9Y6!
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MZ_IKJ/G"@OE'$.R9>9PTZZHYK'N$7,OW&.;D35Z6S97$+4/YP7MFZR1D(V)
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MV7>!FE',-8V)!J:#5#TODEN7VDJ4$G5.^)G-OVFUG<708\S&B$0K(EXY\S#
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M)U,HO;K:4RB<C]6,S6U4?[O?D\S=VQ8Y43'0!PWS_F3G7B]M=E:UN3PXL?'
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M3^ -Q5'^([%M(,M+H^ZDFGKY!U!+ P04    " #1@A!3XA3" OP*  !_A@
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M(]@<7>:6 +O)-@5M34 D6(T!-!RTQ3.E7HB8B9&)XW1.8[+[F>S!=ADZMTP
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MV;Y+[ J*?L,*#E@9!"2]]G181, X:D2@,@05,7ZQF6?9EO WP6,)\800:!X
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M:!IH4F>J"&N?7!>!2$;ZS&;43&X/+_%:(L<K8XM!;6'<4 3!"&@+6A8W?RO
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M7W!R92YX;6S-G%USVC@4AN]W9O^#E[T& MF/)DVVD]#089HVV9"VNWO3$;8
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M9"YU2RCW_ZA>WA0.F1CA5SS7]+S%.ZP*TX4A<XTLWT5ORY^Z4D>*&!MNG)]
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M]#B.3#FD+7W\,WX)JHE<N?1I;-5":EA[U-&2U(OOC:&>1UP%DDF)W?NJ(E<
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M?M)S7_VD[JNOJ$E=E?IO3%>AA!\=0Q565/[+]C5:OBJBHNBFC\]OH-O-/!2
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MFWM( (":@7AZ7Z0QD-V)WP]^[NF:.<322+C9G&T18[YO"I6@F7KI#SN >-G
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M!9F><O(3U[N\5+P5#C(J;Y!<"/75<WIVF2X-IPH41\*_.;;<HF2CIB.Y@H,
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M'19+ 0*7HRLD_*L++;I$;5#9A%*8!G<*M8]LSKZ*ZX5)MQT C6V'--.%.9:
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M'R<^5K_P+,K8A'7[,6ERT647$ML0J7PJ+9)XH5/J=F[DX2,9Y/])F,%/SQ)
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M6-4<Y0I&;[J EE58#9ZT#KHV^,M0 =B:W4K&26)Z/FS#8LOBD<E("FA3[1S
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MJJ[_AP%\,_\ 4$L! A0#%     @ T8(04V6^HNY_D   MV #  D
M     ( !     &5X,5\Q+FAT;5!+ 0(4 Q0    ( -&"$%,#+4]7VPH  &LL
M   )              "  ::0  !E>#5?,2YH=&U02P$"% ,4    " #1@A!3
M/L0-V-L0   =,@  "@              @ &HFP  97@Y.5\R+FAT;5!+ 0(4
M Q0    ( -&"$%.F0$$DD!    \Q   *              "  :NL  !E>#DY
M7S,N:'1M4$L! A0#%     @ T8(04XKJ,0I^'0  QI<   T
M ( !8[T  '(X,3(R,3 X:RYH=&U02P$"% ,4    " #1@A!3,OAX]S4#  #[
M"P  $0              @ $,VP  =&%C="TR,#(Q,#@Q,2YX<V102P$"% ,4
M    " #1@A!3XA3" OP*  !_A@  %0              @ %PW@  =&%C="TR
M,#(Q,#@Q,5]L86(N>&UL4$L! A0#%     @ T8(04[W.5M57!P  WE<  !4
M             ( !G^D  '1A8W0M,C R,3 X,3%?<')E+GAM;%!+ 0(4 Q0
M   ( -&"$%-NM#4H)(8  />(   6              "  2GQ  !T<F%N<V%C
E=&QO9V]?<VUA;&PN:G!G4$L%!@     )  D (@(  (%W 0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
